Defective	O
translocation	O
of	O
protein	B-protein
kinase	I-protein
C	I-protein
in	O
multidrug-resistant	B-cell_line
HL-60	I-cell_line
cells	I-cell_line
confers	O
a	O
reversible	O
loss	O
of	O
phorbol	O
ester-induced	O
monocytic	O
differentiation	O
.	O

Previous	O
studies	O
have	O
demonstrated	O
that	O
human	B-cell_line
HL-60	I-cell_line
myeloid	I-cell_line
leukemia	I-cell_line
cells	I-cell_line
differentiate	O
in	O
response	O
to	O
phorbol	O
esters	O
.	O

This	O
event	O
is	O
associated	O
with	O
induction	O
of	O
the	O
c-jun	B-DNA
early	I-DNA
response	I-DNA
gene	I-DNA
and	O
appearance	O
of	O
a	O
monocytic	O
phenotype	O
.	O

The	O
present	O
studies	O
have	O
examined	O
the	O
effects	O
of	O
vincristine-selected	O
,	O
multidrug	O
resistance	O
on	O
12-O-tetradecanoylphorbol-13-acetate	O
(	O
TPA	O
)	O
-induced	O
HL-60	O
cell	O
differentiation	O
.	O

The	O
results	O
demonstrate	O
that	O
multidrug-resistant	B-cell_line
HL-60	I-cell_line
cells	I-cell_line
,	O
designated	O
HL-60/vinc	O
,	O
fail	O
to	O
respond	O
to	O
TPA	O
with	O
an	O
increase	O
in	O
c-jun	B-RNA
transcripts	I-RNA
or	O
other	O
phenotypic	O
characteristics	O
of	O
monocytic	O
differentiation	O
.	O

By	O
contrast	O
,	O
treatment	O
of	O
HL-60/vinc	B-cell_line
cells	I-cell_line
with	O
okadaic	O
acid	O
,	O
an	O
inhibitor	O
of	O
serine/threonine	B-protein
protein	I-protein
phosphatases	I-protein
,	O
induces	O
c-jun	B-DNA
transcription	O
,	O
growth	O
arrest	O
,	O
and	O
expression	O
of	O
the	O
c-fms	B-DNA
gene	I-DNA
.	O

Studies	O
were	O
also	O
performed	O
with	O
an	O
HL-60/vinc	B-cell_line
revertant	I-cell_line
(	O
HL-60/vinc/R	B-cell_line
)	O
line	O
that	O
has	O
regained	O
partial	O
sensitivity	O
to	O
vincristine	O
.	O

The	O
finding	O
that	O
HL-60/vinc/R	B-cell_line
cells	I-cell_line
respond	O
to	O
TPA	O
with	O
induction	O
of	O
a	O
monocytic	O
phenotype	O
,	O
but	O
not	O
c-jun	B-DNA
expression	O
,	O
suggests	O
that	O
c-jun	B-DNA
induction	O
is	O
not	O
obligatory	O
for	O
monocytic	O
differentiation	O
.	O

Other	O
studies	O
further	O
demonstrate	O
that	O
the	O
jun-B	B-DNA
and	O
fra-1	B-DNA
genes	B-DNA
are	O
induced	O
by	O
TPA	O
in	O
both	O
HL-60/vinc	B-cell_line
and	O
HL-60/vinc/R	B-cell_line
cells	I-cell_line
,	O
whereas	O
c-fos	B-DNA
expression	O
is	O
attenuated	O
in	O
the	O
HL-60/vinc	O
line	O
.	O

Since	O
TPA	O
activates	O
protein	B-protein
kinase	I-protein
C	I-protein
(	O
PKC	B-protein
)	O
,	O
we	O
examined	O
translocation	O
of	O
PKC	B-protein
from	O
the	O
cytosol	O
to	O
the	O
membrane	O
fraction	O
.	O

Although	O
HL-60	B-cell_line
and	O
HL-60/vinc/R	B-cell_line
cells	I-cell_line
demonstrated	O
translocation	O
of	O
PKC	B-protein
activity	O
,	O
this	O
subcellular	O
redistribution	O
was	O
undetectable	O
in	O
HL-60/vinc	B-cell_line
cells	I-cell_line
.	O

Activity	O
of	O
the	O
mitogen-activated	B-protein
protein	I-protein
kinase	I-protein
family	I-protein
with	O
associated	O
phosphorylation	O
of	O
c-Jun	B-protein
Y-peptide	I-protein
was	O
markedly	O
diminished	O
in	O
TPA-treated	B-cell_line
HL-60/vinc	I-cell_line
cells	I-cell_line
,	O
but	O
not	O
in	O
response	O
to	O
okadaic	O
acid	O
.	O

Taken	O
together	O
,	O
these	O
findings	O
suggest	O
that	O
vincristine	O
resistance	O
confers	O
insensitivity	O
to	O
TPA-induced	O
differentiation	O
and	O
can	O
include	O
defects	O
in	O
PKC	B-protein
-mediated	O
signaling	O
events	O
and	O
induction	O
of	O
jun/fos	B-DNA
early	I-DNA
response	I-DNA
gene	I-DNA
expression	O
.	O

THE	NULL
Journat	NULL
or	NULL
BroLOGICAL	NULL
CHEMISTRY	NULL
,	NULL
Â©1993	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

268	NULL
,	NULL
No	NULL
.	NULL

17	NULL
,	NULL
Issue	NULL
of	NULL
June	NULL
15	NULL
,	NULL
pp	NULL
.	NULL

12267-12273	NULL
,	NULL
1993	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

Defective	NULL
Translocation	NULL
of	NULL
Protein	NULL
Kinase	NULL
C	NULL
in	NULL
Multidrug-resistant	NULL
HL-60	NULL
Cells	NULL
Confers	NULL
a	NULL
Reversible	NULL
Loss	NULL
of	NULL
Phorbol	NULL
Ester-induced	NULL
Monocytic	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
January	NULL
5	NULL
,	NULL
1993	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
February	NULL
26	NULL
,	NULL
1993	NULL
)	NULL
Christopher	NULL
A.	NULL
Slapakt	NULL
,	NULL
Surender	NULL
Kharbanda	NULL
,	NULL
Ahamed	NULL
Saleem	NULL
,	NULL
and	NULL
Donald	NULL
W.	NULL
Kufe	NULL
From	NULL
the	NULL
Laboratory	NULL
of	NULL
Clinical	NULL
Pharmacology	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
Previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
human	NULL
HL-60	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
differentiate	NULL
in	NULL
response	NULL
to	NULL
phorbol	NULL
esters	NULL
.	NULL

This	NULL
event	NULL
is	NULL
associated	NULL
with	NULL
induction	NULL
of	NULL
the	NULL
c-jun	NULL
early	NULL
response	NULL
gene	NULL
and	NULL
appearance	NULL
of	NULL
a	NULL
monocytic	NULL
phenotype	NULL
.	NULL

The	NULL
present	NULL
studies	NULL
have	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
vincristine-selected	NULL
,	NULL
multidrug	NULL
resistance	NULL
on	NULL
12-O-tetradecanoylphorbol-13-acetate	NULL
(	NULL
TPA	NULL
)	NULL
-induced	NULL
HL-60	NULL
cell	NULL
differentiation	NULL
.	NULL

The	NULL
results	NULL
demonstrate	NULL
that	NULL
multidrug-resistant	NULL
HL-60	NULL
cells	NULL
,	NULL
designated	NULL
HL-60/vinc	NULL
,	NULL
fail	NULL
to	NULL
respond	NULL
to	NULL
TPA	NULL
with	NULL
an	NULL
increase	NULL
in	NULL
c-Jun	NULL
transcripts	NULL
or	NULL
other	NULL
phenotypic	NULL
characteristics	NULL
of	NULL
monocytic	NULL
differentiation	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
treatment	NULL
of	NULL
HL-60/vine	NULL
cells	NULL
with	NULL
okadaic	NULL
acid	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
serine/threonine	NULL
protein	NULL
phosphatases	NULL
,	NULL
induces	NULL
c-jun	NULL
transcription	NULL
,	NULL
growth	NULL
arrest	NULL
,	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
c-fms	NULL
gene	NULL
.	NULL

Studies	NULL
were	NULL
also	NULL
performed	NULL
with	NULL
an	NULL
HL-60/vine	NULL
revertant	NULL
(	NULL
HL-60/vinc/R	NULL
)	NULL
line	NULL
that	NULL
has	NULL
regained	NULL
partial	NULL
sensitivity	NULL
to	NULL
vincristine	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
HL-60/vine/R	NULL
cells	NULL
respond	NULL
to	NULL
TPA	NULL
with	NULL
induction	NULL
of	NULL
a	NULL
monocytic	NULL
phenotype	NULL
,	NULL
but	NULL
not	NULL
c-jun	NULL
expression	NULL
,	NULL
suggests	NULL
that	NULL
c-jun	NULL
induction	NULL
is	NULL
not	NULL
obligatory	NULL
for	NULL
monocytic	NULL
differentiation	NULL
.	NULL

Other	NULL
studies	NULL
further	NULL
demonstrate	NULL
that	NULL
the	NULL
jun-B	NULL
and	NULL
fra-1	NULL
genes	NULL
are	NULL
induced	NULL
by	NULL
TPA	NULL
in	NULL
both	NULL
HL-60/vine	NULL
and	NULL
HL-60/vine/R	NULL
cells	NULL
,	NULL
whereas	NULL
c-fos	NULL
expression	NULL
is	NULL
attenuated	NULL
in	NULL
the	NULL
HL-60/vinc	NULL
line	NULL
.	NULL

Since	NULL
TPA	NULL
activates	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
,	NULL
we	NULL
examined	NULL
translocation	NULL
of	NULL
PKC	NULL
from	NULL
the	NULL
cytosol	NULL
to	NULL
the	NULL
membrane	NULL
fraction	NULL
.	NULL

Although	NULL
HL-60	NULL
and	NULL
HL-60/vinc/R	NULL
cells	NULL
demonstrated	NULL
translocation	NULL
of	NULL
PKC	NULL
activity	NULL
,	NULL
this	NULL
subcellular	NULL
redistribution	NULL
was	NULL
undetectable	NULL
in	NULL
HL-6O0/vince	NULL
cells	NULL
.	NULL

Activity	NULL
of	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
family	NULL
with	NULL
associated	NULL
phosphorylation	NULL
of	NULL
c-Jun	NULL
Y-peptide	NULL
was	NULL
markedly	NULL
diminished	NULL
in	NULL
TPA-treated	NULL
HL-60/vinc	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
in	NULL
response	NULL
to	NULL
okadaic	NULL
acid	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
vincristine	NULL
resistance	NULL
confers	NULL
insensitivity	NULL
to	NULL
TPA-induced	NULL
differentiation	NULL
and	NULL
can	NULL
include	NULL
defects	NULL
in	NULL
PKC-mediated	NULL
signaling	NULL
events	NULL
and	NULL
induction	NULL
of	NULL
jun/fos	NULL
early	NULL
response	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
c-jun	NULL
gene	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
*	NULL
This	NULL
investigation	NULL
was	NULL
supported	NULL
by	NULL
United	NULL
States	NULL
Public	NULL
Health	NULL
Service	NULL
Grant	NULL
Number	NULL
CA42802	NULL
awarded	NULL
by	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
by	NULL
a	NULL
Burroughs	NULL
Wellcome	NULL
Award	NULL
in	NULL
Clinical	NULL
Pharmacology	NULL
(	NULL
to	NULL
D.	NULL
W.	NULL
K.	NULL
)	NULL
and	NULL
by	NULL
a	NULL
Clinical	NULL
Investigator	NULL
Award	NULL
CA-01613	NULL
from	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
(	NULL
to	NULL
C.	NULL
A.	NULL
S.	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

+	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

cellular	NULL
proliferation	NULL
and	NULL
differentiation	NULL
(	NULL
1	NULL
)	NULL
.	NULL

This	NULL
gene	NULL
codes	NULL
for	NULL
a	NULL
major	NULL
form	NULL
of	NULL
the	NULL
AP-1	NULL
transcription	NULL
factor	NULL
(	NULL
2-6	NULL
)	NULL
.	NULL

AP-1	NULL
polypeptides	NULL
bind	NULL
to	NULL
a	NULL
heptameric	NULL
DNA	NULL
consensus	NULL
sequence	NULL
TGA	NULL
(	NULL
G/C	NULL
)	NULL
TCA	NULL
,	NULL
which	NULL
regulates	NULL
the	NULL
transcription	NULL
of	NULL
genes	NULL
responsive	NULL
to	NULL
phorbol	NULL
esters	NULL
,	NULL
growth	NULL
factors	NULL
,	NULL
and	NULL
transforming	NULL
proteins	NULL
(	NULL
3	NULL
,	NULL
6-12	NULL
)	NULL
.	NULL

The	NULL
c-jun	NULL
gene	NULL
is	NULL
a	NULL
member	NULL
of	NULL
a	NULL
multigene	NULL
family	NULL
,	NULL
which	NULL
codes	NULL
for	NULL
leucine	NULL
zipper	NULL
transcription	NULL
factors	NULL
and	NULL
includes	NULL
among	NULL
others	NULL
the	NULL
jun-B	NULL
,	NULL
c-fos	NULL
,	NULL
fos-B	NULL
,	NULL
and	NULL
fra-1	NULL
genes	NULL
.	NULL

The	NULL
affinity	NULL
of	NULL
Jun/AP-1	NULL
for	NULL
DNA	NULL
binding	NULL
to	NULL
the	NULL
phorbol	NULL
ester-responsive	NULL
element	NULL
(	NULL
TRE	NULL
)	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
formation	NULL
of	NULL
Jun/Jun	NULL
homodimers	NULL
or	NULL
heterodimers	NULL
with	NULL
products	NULL
of	NULL
the	NULL
fos	NULL
genes	NULL
(	NULL
13-15	NULL
)	NULL
.	NULL

The	NULL
product	NULL
of	NULL
the	NULL
jun-B	NULL
gene	NULL
also	NULL
interacts	NULL
with	NULL
c-Fos	NULL
and	NULL
the	NULL
TRE	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
finding	NULL
that	NULL
c-jun	NULL
and	NULL
jun-B	NULL
differ	NULL
in	NULL
response	NULL
to	NULL
certain	NULL
extracellular	NULL
stimuli	NULL
has	NULL
suggested	NULL
that	NULL
these	NULL
gene	NULL
products	NULL
play	NULL
distinct	NULL
roles	NULL
in	NULL
gene	NULL
regulation	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
precise	NULL
role	NULL
of	NULL
Jun/AP-1	NULL
in	NULL
growth	NULL
and	NULL
differentiation	NULL
is	NULL
unclear	NULL
.	NULL

Nonetheless	NULL
,	NULL
recent	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
Jun	NULL
is	NULL
required	NULL
for	NULL
cell	NULL
cycle	NULL
progression	NULL
into	NULL
S	NULL
phase	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Other	NULL
work	NULL
has	NULL
shown	NULL
that	NULL
ectopic	NULL
expression	NULL
of	NULL
c-jun	NULL
results	NULL
in	NULL
differentiation	NULL
of	NULL
P19	NULL
embryonal	NULL
carcinoma	NULL
cells	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
several	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
c-jun	NULL
expression	NULL
is	NULL
associated	NULL
with	NULL
differentiation	NULL
of	NULL
human	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
(	NULL
20-23	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
HL-60	NULL
promye-locytic	NULL
leukemia	NULL
cells	NULL
differentiate	NULL
along	NULL
the	NULL
monocytic	NULL
lineage	NULL
following	NULL
exposure	NULL
to	NULL
certain	NULL
agents	NULL
such	NULL
as	NULL
12-O-tetradecanoylphorbol-13-acetate	NULL
(	NULL
TPA	NULL
)	NULL
(	NULL
24-26	NULL
)	NULL
.	NULL

The	NULL
differentiated	NULL
HL-60	NULL
phenotype	NULL
is	NULL
characterized	NULL
by	NULL
growth	NULL
inhibition	NULL
,	NULL
increased	NULL
adherence	NULL
and	NULL
an	NULL
increase	NULL
in	NULL
monocyte	NULL
cell	NULL
surface	NULL
antigen	NULL
expression	NULL
(	NULL
24-26	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
induction	NULL
of	NULL
c-jun	NULL
,	NULL
jun-B	NULL
and	NULL
c-fos	NULL
gene	NULL
expression	NULL
,	NULL
monocytic	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
decrease	NULL
in	NULL
c-myc	NULL
mRNA	NULL
levels	NULL
and	NULL
increases	NULL
in	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
and	NULL
c-fms	NULL
transcripts	NULL
(	NULL
27-29	NULL
)	NULL
.	NULL

The	NULL
present	NULL
work	NULL
has	NULL
utilized	NULL
HL-60	NULL
cells	NULL
selected	NULL
for	NULL
vincristine	NULL
resistance	NULL
(	NULL
30	NULL
)	NULL
to	NULL
study	NULL
early	NULL
response	NULL
gene	NULL
expression	NULL
during	NULL
TPA-induced	NULL
differentiation	NULL
.	NULL

These	NULL
cells	NULL
,	NULL
designated	NULL
HL-60/vinc	NULL
,	NULL
overexpress	NULL
the	NULL
multidrug	NULL
resistance	NULL
(	NULL
mdr	NULL
)	NULL
gene	NULL
product	NULL
or	NULL
P-glycoprotein	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
a	NULL
revertant	NULL
(	NULL
HL-60/vinc/R	NULL
)	NULL
which	NULL
has	NULL
regained	NULL
partial	NULL
sensitivity	NULL
to	NULL
vincristine	NULL
expresses	NULL
relatively	NULL
low	NULL
levels	NULL
of	NULL
mdr	NULL
transcripts	NULL
(	NULL
30	NULL
)	NULL
.	NULL

The	NULL
results	NULL
demonstrate	NULL
that	NULL
HL-60/vine	NULL
cells	NULL
are	NULL
unresponsive	NULL
to	NULL
TPA-induced	NULL
monocytic	NULL
differentiation	NULL
,	NULL
whereas	NULL
the	NULL
HL-60/vinc/R	NULL
cell	NULL
line	NULL
has	NULL
regained	NULL
the	NULL
capacity	NULL
to	NULL
express	NULL
the	NULL
differentiated	NULL
phenotype	NULL
.	NULL

We	NULL
also	NULL
demonstrate	NULL
'	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
TRE	NULL
,	NULL
phorbol	NULL
ester-responsive	NULL
ele-ment	NULL
;	NULL
TPA	NULL
,	NULL
12-O-tetradecanoylphorbol-13-acetate	NULL
;	NULL
TNF	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
;	NULL
PKC	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
;	NULL
MAP	NULL
,	NULL
mitogen-activated	NULL
protein	NULL
;	NULL
MEL	NULL
,	NULL
murine	NULL
erythroleukemia	NULL
;	NULL
HMBA	NULL
,	NULL
hexamethylene	NULL
bisace-tamide	NULL
;	NULL
MBP	NULL
,	NULL
myelin	NULL
basic	NULL
protein	NULL
;	NULL
kb	NULL
,	NULL
kilobase	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
.	NULL

12267	NULL
12268	NULL
that	NULL
both	NULL
cell	NULL
lines	NULL
are	NULL
defective	NULL
in	NULL
signaling	NULL
events	NULL
that	NULL
confer	NULL
TPA	NULL
inducibility	NULL
of	NULL
the	NULL
c-jun	NULL
gene	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
Culture-HL-60	NULL
,	NULL
HL-60/vine	NULL
,	NULL
and	NULL
HL-60/vinc/R	NULL
cells	NULL
were	NULL
grown	NULL
at	NULL
a	NULL
density	NULL
of	NULL
1-2	NULL
x	NULL
10Â°/ml	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
supplemented	NULL
with	NULL
100	NULL
units/ml	NULL
penicillin	NULL
,	NULL
100	NULL
ug/ml	NULL
streptomycin	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
L-glutamine	NULL
.	NULL

The	NULL
multidrug-resistant	NULL
HL-60/vine	NULL
subline	NULL
was	NULL
selected	NULL
in	NULL
increasing	NULL
concentrations	NULL
of	NULL
vincristine	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
.	NULL

The	NULL
HL-60/vinc/R	NULL
revertant	NULL
was	NULL
obtained	NULL
by	NULL
prolonged	NULL
passage	NULL
of	NULL
HL-60/vine	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
drug	NULL
(	NULL
30	NULL
)	NULL
.	NULL

To	NULL
insure	NULL
that	NULL
cells	NULL
were	NULL
in	NULL
logarithmic	NULL
growth	NULL
phase	NULL
,	NULL
cultures	NULL
were	NULL
seeded	NULL
at	NULL
5	NULL
x	NULL
10*-1	NULL
x	NULL
10Â°/ml	NULL
24	NULL
h	NULL
prior	NULL
to	NULL
treatment	NULL
with	NULL
32	NULL
nM	NULL
TPA	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
40	NULL
ng/ml	NULL
okadaic	NULL
acid	NULL
(	NULL
Moana	NULL
Bioproducts	NULL
Inc.	NULL
,	NULL
Hon-olulu	NULL
,	NULL
HI	NULL
)	NULL
,	NULL
or	NULL
0.5	NULL
uM	NULL
calcitriol	NULL
(	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
Hoffmann-La	NULL
Roche	NULL
,	NULL
Nutley	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

Isolation	NULL
and	NULL
Analysis	NULL
of	NULL
RNA-Total	NULL
cellular	NULL
RNA	NULL
was	NULL
purified	NULL
by	NULL
the	NULL
guanidine	NULL
isothiocyanate-cesium	NULL
chloride	NULL
technique	NULL
(	NULL
32	NULL
)	NULL
.	NULL

The	NULL
RNA	NULL
was	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
through	NULL
1	NULL
%	NULL
agarose-formalde-hyde	NULL
gels	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
or	NULL
Gene-Screen	NULL
Plus	NULL
filters	NULL
and	NULL
hybridized	NULL
to	NULL
the	NULL
following	NULL
**P	NULL
-labeled	NULL
DNA	NULL
probes	NULL
:	NULL
(	NULL
a	NULL
)	NULL
the	NULL
1.8-kb	NULL
BamHI/EcoRI	NULL
insert	NULL
of	NULL
a	NULL
human	NULL
c-jun	NULL
gene	NULL
purified	NULL
from	NULL
a	NULL
pBluescript	NULL
SK	NULL
(	NULL
+	NULL
)	NULL
plasmid	NULL
(	NULL
3	NULL
)	NULL
;	NULL
(	NULL
b	NULL
)	NULL
the	NULL
1.5-kb	NULL
EcoRI	NULL
fragment	NULL
of	NULL
the	NULL
murine	NULL
jun-B	NULL
cDNA	NULL
from	NULL
the	NULL
p465.20	NULL
plasmid	NULL
(	NULL
33	NULL
)	NULL
;	NULL
(	NULL
c	NULL
)	NULL
the	NULL
0.9-kb	NULL
Scal/Ncol	NULL
insert	NULL
of	NULL
a	NULL
human	NULL
c-fos	NULL
gene	NULL
purified	NULL
from	NULL
the	NULL
pe-fos-1	NULL
plasmid	NULL
(	NULL
34	NULL
)	NULL
;	NULL
(	NULL
d	NULL
)	NULL
the	NULL
2-kb	NULL
EcoRI	NULL
insert	NULL
of	NULL
murine	NULL
fos-B	NULL
in	NULL
plasmid	NULL
pUC19	NULL
(	NULL
35	NULL
)	NULL
;	NULL
(	NULL
e	NULL
)	NULL
the	NULL
1.5-kb	NULL
EcoRI	NULL
insert	NULL
of	NULL
the	NULL
fra-1	NULL
gene	NULL
in	NULL
the	NULL
pSp65-fra-1	NULL
plasmid	NULL
(	NULL
36	NULL
)	NULL
;	NULL
(	NULL
f	NULL
)	NULL
the	NULL
2.0-kb	NULL
PstI	NULL
insert	NULL
of	NULL
a	NULL
chicken	NULL
B-actin	NULL
gene	NULL
purified	NULL
from	NULL
the	NULL
pA1	NULL
plasmid	NULL
(	NULL
37	NULL
)	NULL
;	NULL
(	NULL
g	NULL
)	NULL
the	NULL
4.0-kb	NULL
EcoRI	NULL
fragment	NULL
of	NULL
the	NULL
human	NULL
c-fms	NULL
gene	NULL
purified	NULL
from	NULL
the	NULL
pe-fms-102	NULL
plasmid	NULL
(	NULL
38	NULL
)	NULL
;	NULL
and	NULL
(	NULL
A	NULL
)	NULL
the	NULL
1.9-kb	NULL
BamHI/PstI	NULL
insert	NULL
of	NULL
a	NULL
human	NULL
TNF	NULL
cDNA	NULL
purified	NULL
from	NULL
the	NULL
pFE4	NULL
plasmid	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Hybridizations	NULL
were	NULL
performed	NULL
at	NULL
42	NULL
Â°C	NULL
for	NULL
24	NULL
h	NULL
in	NULL
50	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
formamide	NULL
,	NULL
2	NULL
x	NULL
SSC	NULL
,	NULL
1	NULL
x	NULL
Denhardt	NULL
's	NULL
solution	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
and	NULL
200	NULL
mg/ml	NULL
salmon	NULL
sperm	NULL
DNA	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
2	NULL
x	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
then	NULL
in	NULL
0.1	NULL
x	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
at	NULL
60	NULL
Â°C	NULL
for	NULL
1	NULL
h.	NULL
Flow	NULL
Cytometry-Monoclonal	NULL
antibody	NULL
Mol	NULL
(	NULL
Macl	NULL
,	NULL
CD11b	NULL
)	NULL
was	NULL
used	NULL
as	NULL
previously	NULL
described	NULL
to	NULL
detect	NULL
cell	NULL
surface	NULL
expression	NULL
by	NULL
flow	NULL
cytometry	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
above	NULL
background	NULL
fluorescence	NULL
determined	NULL
by	NULL
incubation	NULL
with	NULL
an	NULL
isotype	NULL
identical	NULL
control	NULL
antibody	NULL
.	NULL

Nuclear	NULL
Run-on	NULL
Assays-Nuclei	NULL
were	NULL
isolated	NULL
from	NULL
10Â°	NULL
cells	NULL
and	NULL
suspended	NULL
in	NULL
100	NULL
wl	NULL
of	NULL
glycerol	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
8.3	NULL
,	NULL
40	NULL
%	NULL
glycerol	NULL
,	NULL
5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
and	NULL
0.1	NULL
mm	NULL
EDTA	NULL
)	NULL
.	NULL

An	NULL
equal	NULL
volume	NULL
of	NULL
reaction	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
5	NULL
mm	NULL
MgCl	NULL
;	NULL
,	NULL
100	NULL
mm	NULL
KCl	NULL
,	NULL
1	NULL
mM	NULL
ATP	NULL
,	NULL
1	NULL
mm	NULL
CTP	NULL
,	NULL
1	NULL
mM	NULL
GTP	NULL
,	NULL
and	NULL
5	NULL
mM	NULL
dithiothreitol	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
nuclei	NULL
in	NULL
suspension	NULL
and	NULL
incubated	NULL
at	NULL
26	NULL
Â°C	NULL
for	NULL
30	NULL
min	NULL
with	NULL
250	NULL
LCi	NULL
of	NULL
[	NULL
a-	NULL
``	NULL
``	NULL
P	NULL
]	NULL
UTP	NULL
(	NULL
3000	NULL
Ci/mmol	NULL
;	NULL
Du	NULL
Pont	NULL
)	NULL
.	NULL

The	NULL
nuclear	NULL
RNA	NULL
was	NULL
isolated	NULL
as	NULL
described	NULL
(	NULL
21	NULL
)	NULL
and	NULL
hybridized	NULL
to	NULL
the	NULL
following	NULL
DNAs	NULL
:	NULL
(	NULL
a	NULL
)	NULL
a	NULL
PstI	NULL
digest	NULL
of	NULL
the	NULL
pA1	NULL
plasmid	NULL
containing	NULL
a	NULL
fragment	NULL
of	NULL
the	NULL
chicken	NULL
S-actin	NULL
gene	NULL
(	NULL
37	NULL
)	NULL
and	NULL
(	NULL
b	NULL
)	NULL
a	NULL
BamHI/EcoRI	NULL
digest	NULL
of	NULL
the	NULL
pBluescript	NULL
SK	NULL
(	NULL
+	NULL
)	NULL
plasmid	NULL
containing	NULL
a	NULL
fragment	NULL
of	NULL
the	NULL
human	NULL
c-jun	NULL
gene	NULL
(	NULL
3	NULL
)	NULL
.	NULL

The	NULL
digested	NULL
DNAs	NULL
were	NULL
run	NULL
in	NULL
1	NULL
%	NULL
agarose	NULL
gels	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
filters	NULL
.	NULL

Hybridizations	NULL
were	NULL
performed	NULL
with	NULL
10	NULL
``	NULL
cpm	NULL
of	NULL
P-labeled	NULL
RNA/ml	NULL
!	NULL

in	NULL
10	NULL
mm	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
4	NULL
x	NULL
SSC	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
2	NULL
x	NULL
Denhardt	NULL
's	NULL
solution	NULL
,	NULL
40	NULL
%	NULL
formamide	NULL
,	NULL
and	NULL
100	NULL
ug/ml	NULL
yeast	NULL
tRNA	NULL
for	NULL
72	NULL
h	NULL
at	NULL
42	NULL
Â°C	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
washed	NULL
in	NULL
2	NULL
x	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
at	NULL
37	NULL
Â°C	NULL
for	NULL
30	NULL
min	NULL
,	NULL
200	NULL
ng/ml	NULL
RNase	NULL
A	NULL
in	NULL
2	NULL
x	NULL
SSC	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
5	NULL
min	NULL
,	NULL
and	NULL
0.1	NULL
x	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
at	NULL
42	NULL
Â°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Autoradiography	NULL
was	NULL
performed	NULL
by	NULL
exposure	NULL
to	NULL
Kodak	NULL
X-Omat	NULL
XAR	NULL
film	NULL
using	NULL
an	NULL
intensifying	NULL
screen	NULL
.	NULL

Protein	NULL
Kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
Assays-Cells	NULL
(	NULL
10	NULL
'	NULL
)	NULL
were	NULL
suspended	NULL
in	NULL
0.4	NULL
ml	NULL
of	NULL
ice-cold	NULL
lysis	NULL
buffer	NULL
(	NULL
20	NULL
mm	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
0.5	NULL
mm	NULL
EDTA	NULL
,	NULL
0.5	NULL
mm	NULL
EGTA	NULL
,	NULL
10	NULL
mM	NULL
2-mercaptoethanol	NULL
,	NULL
25	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
and	NULL
25	NULL
ug/ml	NULL
aprotinin	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
disrupted	NULL
by	NULL
passage	NULL
through	NULL
a	NULL
25-gauge	NULL
needle	NULL
and	NULL
then	NULL
centrifuged	NULL
at	NULL
15,000	NULL
x	NULL
g	NULL
for	NULL
20	NULL
min	NULL
at	NULL
4	NULL
Â°C	NULL
.	NULL

The	NULL
supernatant	NULL
(	NULL
cytosolic	NULL
fraction	NULL
)	NULL
was	NULL
applied	NULL
to	NULL
DEAE-cellulose	NULL
for	NULL
partial	NULL
purification	NULL
of	NULL
PKC	NULL
.	NULL

The	NULL
pellet	NULL
(	NULL
membrane	NULL
fraction	NULL
)	NULL
was	NULL
resuspended	NULL
in	NULL
lysis	NULL
buffer	NULL
with	NULL
0.5	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
sonicated	NULL
for	NULL
15	NULL
s	NULL
on	NULL
ice	NULL
,	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
60	NULL
min	NULL
,	NULL
and	NULL
then	NULL
centrifuged	NULL
at	NULL
15,000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4Â°C	NULL
.	NULL

The	NULL
supernatant	NULL
(	NULL
detergent-solubilized	NULL
membrane	NULL
fraction	NULL
)	NULL
was	NULL
used	NULL
to	NULL
partially	NULL
purify	NULL
PKC	NULL
on	NULL
DEAE-cellulose	NULL
columns	NULL
.	NULL

PKC	NULL
activity	NULL
was	NULL
determined	NULL
as	NULL
described	NULL
(	NULL
Ref	NULL
.	NULL

41	NULL
and	NULL
Protein	NULL
Kinase	NULL
C	NULL
Assay	NULL
System	NULL
,	NULL
GIBCO/	NULL
BRL	NULL
)	NULL
.	NULL

The	NULL
partially	NULL
purified	NULL
protein	NULL
fractions	NULL
were	NULL
incubated	NULL
for	NULL
5	NULL
min	NULL
at	NULL
30	NULL
Â°C	NULL
in	NULL
phospholipid	NULL
(	NULL
phosphatidylserine	NULL
and	NULL
phorbol	NULL
ester	NULL
in	NULL
Triton	NULL
X-100	NULL
mixed	NULL
micelles	NULL
;	NULL
GIBCO/BRL	NULL
)	NULL
,	NULL
[	NULL
y-P	NULL
]	NULL
JATP	NULL
(	NULL
6000	NULL
Vincristine	NULL
Resistance	NULL
Blocks	NULL
TPA-mediated	NULL
Signaling	NULL
Events	NULL
Ci/mmol	NULL
;	NULL
Du	NULL
Pont-New	NULL
England	NULL
Nuclear	NULL
)	NULL
,	NULL
and	NULL
PKC	NULL
synthetic	NULL
pep-tide	NULL
from	NULL
myelin	NULL
basic	NULL
protein	NULL
(	NULL
GIBCO/BRL	NULL
)	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
dried	NULL
on	NULL
phosphocellulose	NULL
,	NULL
washed	NULL
in	NULL
1	NULL
%	NULL
H	NULL
;	NULL
PO	NULL
,	NULL
,	NULL
and	NULL
assayed	NULL
by	NULL
scintillation	NULL
counting	NULL
.	NULL

PKC	NULL
activity	NULL
was	NULL
determined	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Protein	NULL
Kinase	NULL
C	NULL
Assay	NULL
System	NULL
(	NULL
GIBCO/BRL	NULL
)	NULL
.	NULL

Mitogen-activated	NULL
Protein	NULL
(	NULL
MAP	NULL
)	NULL
Kinase	NULL
Assays-MAP	NULL
kinase	NULL
activity	NULL
was	NULL
assayed	NULL
in	NULL
HL-60	NULL
and	NULL
HL-60/vine	NULL
cells	NULL
using	NULL
cytosolic	NULL
extracts	NULL
as	NULL
described	NULL
(	NULL
42	NULL
,	NULL
43	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
samples	NULL
of	NULL
protein-normalized	NULL
cytosolic	NULL
extracts	NULL
(	NULL
0.75	NULL
ml	NULL
)	NULL
were	NULL
loaded	NULL
onto	NULL
Q-Sepharose	NULL
fast-flow	NULL
columns	NULL
(	NULL
Pharmacia	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
previously	NULL
equilibrated	NULL
with	NULL
buffer	NULL
A	NULL
(	NULL
20	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
0.5	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mm	NULL
EGTA	NULL
,	NULL
10	NULL
mM	NULL
2-mercaptoethanol	NULL
,	NULL
0.25	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
10	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
10	NULL
ug/ml	NULL
aprotinin	NULL
,	NULL
100	NULL
uM	NULL
sodium	NULL
vanadate	NULL
,	NULL
0.15	NULL
M	NULL
NaCl	NULL
)	NULL
.	NULL

Protein	NULL
was	NULL
eluted	NULL
with	NULL
0.6	NULL
ml	NULL
of	NULL
buffer	NULL
A	NULL
containing	NULL
0.55	NULL
M	NULL
NaCl	NULL
.	NULL

Aliquots	NULL
(	NULL
20	NULL
ul	NULL
)	NULL
of	NULL
the	NULL
eluted	NULL
samples	NULL
were	NULL
assayed	NULL
for	NULL
the	NULL
ability	NULL
to	NULL
phosphorylate	NULL
MBP	NULL
or	NULL
Y-peptide	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Ca**	NULL
and	NULL
phospholipid	NULL
after	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
TPA	NULL
for	NULL
30	NULL
min	NULL
or	NULL
okadaic	NULL
acid	NULL
for	NULL
3	NULL
h	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Protein	NULL
concentrations	NULL
of	NULL
the	NULL
cellular	NULL
extracts	NULL
were	NULL
determined	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Bradford	NULL
(	NULL
71	NULL
)	NULL
using	NULL
bovine	NULL
serum	NULL
albumin	NULL
as	NULL
a	NULL
standard	NULL
.	NULL

RESULTS	NULL
Previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
HL-60	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
respond	NULL
to	NULL
TPA	NULL
treatment	NULL
with	NULL
induction	NULL
of	NULL
c-jun	NULL
gene	NULL
expression	NULL
and	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
monocytic	NULL
phenotype	NULL
.	NULL

In	NULL
the	NULL
present	NULL
work	NULL
,	NULL
we	NULL
sought	NULL
to	NULL
determine	NULL
whether	NULL
similar	NULL
responses	NULL
occur	NULL
in	NULL
HL-60	NULL
cells	NULL
selected	NULL
for	NULL
resistance	NULL
to	NULL
the	NULL
effects	NULL
of	NULL
cytotoxic	NULL
agents	NULL
.	NULL

In	NULL
order	NULL
to	NULL
address	NULL
this	NULL
issue	NULL
,	NULL
we	NULL
have	NULL
used	NULL
a	NULL
vincristine-selected	NULL
,	NULL
multidrug-resistant	NULL
HL-60	NULL
subclone	NULL
,	NULL
designated	NULL
HL-60/vine	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Low	NULL
but	NULL
detectable	NULL
levels	NULL
of	NULL
c-jun	NULL
transcripts	NULL
were	NULL
present	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Whereas	NULL
HL-60	NULL
cells	NULL
respond	NULL
to	NULL
TPA	NULL
with	NULL
increases	NULL
in	NULL
c-jun	NULL
mRNA	NULL
levels	NULL
(	NULL
20	NULL
)	NULL
,	NULL
there	NULL
was	NULL
little	NULL
if	NULL
any	NULL
effect	NULL
of	NULL
this	NULL
agent	NULL
on	NULL
c-jun	NULL
expression	NULL
in	NULL
the	NULL
HL-60/vine	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

However	NULL
,	NULL
exposure	NULL
of	NULL
HL-60/vine	NULL
cells	NULL
to	NULL
TPA	NULL
was	NULL
associated	NULL
with	NULL
increases	NULL
in	NULL
jun-B	NULL
mRNA	NULL
that	NULL
were	NULL
detectable	NULL
at	NULL
1	NULL
h	NULL
and	NULL
persisted	NULL
through	NULL
24	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

This	NULL
pattern	NULL
was	NULL
comparable	NULL
with	NULL
that	NULL
obtained	NULL
in	NULL
TPA-treated	NULL
parental	NULL
HL-60	NULL
cells	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Since	NULL
proteins	NULL
encoded	NULL
by	NULL
members	NULL
HL-60/vinc	NULL
28S-	NULL
a	NULL
w	NULL
i	NULL
u	NULL
a	NULL
c-Jun	NULL
18s-28S-	NULL
jun-B	NULL
18s-	NULL
=	NULL
W	NULL
@	NULL
MwwÂ®	NULL
!	NULL

28S-	NULL
#	NULL
*	NULL
c-fos	NULL
18s-28S-	NULL
18s-188-	NULL
.	NULL

Â®t	NULL
we	NULL
Â®	NULL
fra-	NULL
1	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Effects	NULL
of	NULL
TPA	NULL
on	NULL
c-jun	NULL
,	NULL
jun-B	NULL
,	NULL
c-fos	NULL
,	NULL
fos-B	NULL
,	NULL
and	NULL
fra-1	NULL
expression	NULL
in	NULL
HL-60/vine	NULL
cells	NULL
.	NULL

HL-60/vine	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
32	NULL
nm	NULL
TPA	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
was	NULL
hybridized	NULL
to	NULL
P-labeled	NULL
c-jun	NULL
,	NULL
jun-B	NULL
,	NULL
c-fos	NULL
,	NULL
fos-B	NULL
,	NULL
and	NULL
fra-1	NULL
probes	NULL
.	NULL

Ethidium	NULL
bromide	NULL
staining	NULL
of	NULL
the	NULL
gels	NULL
demonstrated	NULL
equal	NULL
loading	NULL
of	NULL
the	NULL
lanes	NULL
.	NULL

Vincristine	NULL
Resistance	NULL
Blocks	NULL
TPA-mediated	NULL
Signaling	NULL
Events	NULL
TABLE	NULL
I	NULL
Characteristics	NULL
of	NULL
HL-60	NULL
cell	NULL
variants	NULL
Cell	NULL
growth	NULL
,	NULL
adherence	NULL
and	NULL
Macl	NULL
positivity	NULL
were	NULL
determined	NULL
after	NULL
24-h	NULL
exposures	NULL
to	NULL
TPA	NULL
.	NULL

HL-60	NULL
~	NULL
HL-60/vine	NULL
-_	NULL
HL-60/vinc/R	NULL
Controli	NULL
â	NULL
i	NULL
â	NULL
vli	NULL
:	NULL
Control	NULL
iTPA	NULL
Canard	NULL
?	NULL

if	NULL
)	NULL
;	NULL
Cell	NULL
growth	NULL
``	NULL
100	NULL
50	NULL
100	NULL
96	NULL
+7	NULL
100	NULL
65	NULL
+5	NULL
AdherenceÂ®	NULL
-	NULL
+++	NULL
-	NULL
-	NULL
-	NULL
++	NULL
Mac1*cells	NULL
(	NULL
%	NULL
)	NULL
â	NULL
2	NULL
%	NULL
2	NULL
TB	NULL
%	NULL
8	NULL
2	NULL
%	NULL
1	NULL
17	NULL
%	NULL
10	NULL
544	NULL
6018	NULL
*	NULL
Growth	NULL
(	NULL
%	NULL
of	NULL
control	NULL
)	NULL
is	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
S.D	NULL
.	NULL

of	NULL
three	NULL
determinations	NULL
.	NULL

Â®	NULL
Adherence	NULL
:	NULL
0-5	NULL
%	NULL
(	NULL
-	NULL
)	NULL
,	NULL
50-75	NULL
%	NULL
(	NULL
++	NULL
)	NULL
,	NULL
and	NULL
75-100	NULL
%	NULL
(	NULL
+++	NULL
)	NULL
.	NULL

Â©	NULL
Results	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
S.D	NULL
.	NULL

of	NULL
two	NULL
determinations	NULL
.	NULL

of	NULL
the	NULL
jun	NULL
gene	NULL
family	NULL
form	NULL
heterodimers	NULL
with	NULL
fos	NULL
gene	NULL
products	NULL
(	NULL
13-15	NULL
)	NULL
,	NULL
we	NULL
similarly	NULL
studied	NULL
the	NULL
expression	NULL
of	NULL
c-fos	NULL
,	NULL
fos-B	NULL
,	NULL
and	NULL
the	NULL
fos-related	NULL
gene	NULL
,	NULL
fra-1	NULL
.	NULL

TPA	NULL
rapidly	NULL
induces	NULL
c-fos	NULL
,	NULL
fos-B	NULL
,	NULL
and	NULL
fra-1	NULL
transcripts	NULL
(	NULL
within	NULL
1	NULL
h	NULL
)	NULL
in	NULL
HL-60	NULL
cells	NULL
(	NULL
28	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
response	NULL
of	NULL
the	NULL
c-fos	NULL
or	NULL
fos-B	NULL
gene	NULL
in	NULL
TPA-treated	NULL
HL-60/vinc	NULL
cells	NULL
was	NULL
markedly	NULL
attenuated	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
the	NULL
parental	NULL
line	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
and	NULL
Ref	NULL
.	NULL

20	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
fra-1	NULL
,	NULL
however	NULL
,	NULL
was	NULL
comparable	NULL
in	NULL
both	NULL
the	NULL
HL-60	NULL
and	NULL
the	NULL
HL-60/vince	NULL
cells	NULL
.	NULL

These	NULL
findings	NULL
indicated	NULL
that	NULL
the	NULL
HL-60/	NULL
vine	NULL
cells	NULL
are	NULL
defective	NULL
in	NULL
TPA-induced	NULL
signaling	NULL
events	NULL
that	NULL
regulate	NULL
c-jun	NULL
,	NULL
c-fos	NULL
,	NULL
fos-	NULL
B	NULL
,	NULL
but	NULL
not	NULL
jun-B	NULL
or	NULL
fra-1	NULL
,	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
HL-60/vinc	NULL
cells	NULL
respond	NULL
to	NULL
TPA	NULL
without	NULL
increases	NULL
in	NULL
c-Jun	NULL
expression	NULL
suggested	NULL
that	NULL
other	NULL
defects	NULL
may	NULL
exist	NULL
in	NULL
terms	NULL
of	NULL
appearance	NULL
of	NULL
the	NULL
TPA-induced	NULL
monocytic	NULL
phenotype	NULL
.	NULL

Indeed	NULL
,	NULL
whereas	NULL
TPA	NULL
inhibits	NULL
growth	NULL
of	NULL
HL-60	NULL
cells	NULL
,	NULL
exposure	NULL
of	NULL
HL-60/vine	NULL
cells	NULL
to	NULL
this	NULL
agent	NULL
had	NULL
little	NULL
if	NULL
any	NULL
antiproliferative	NULL
effect	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

TPA	NULL
also	NULL
had	NULL
no	NULL
detectable	NULL
effect	NULL
on	NULL
adherence	NULL
of	NULL
HL-60/vine	NULL
cells	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
TPA	NULL
had	NULL
little	NULL
effect	NULL
on	NULL
expression	NULL
of	NULL
the	NULL
Macl	NULL
cell	NULL
surface	NULL
differentiation	NULL
antigen	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Other	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
TPA-induced	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
is	NULL
associated	NULL
with	NULL
increased	NULL
expression	NULL
of	NULL
the	NULL
TNF	NULL
and	NULL
c-fms	NULL
genes	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Northern	NULL
analysis	NULL
of	NULL
TPA-treated	NULL
HL-60/vine	NULL
cells	NULL
,	NULL
however	NULL
,	NULL
failed	NULL
to	NULL
demonstrate	NULL
changes	NULL
in	NULL
TNF	NULL
or	NULL
c-fms	NULL
mRNA	NULL
levels	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
demonstrate	NULL
that	NULL
HL-60/vine	NULL
cells	NULL
are	NULL
resistant	NULL
to	NULL
TPA-induced	NULL
monocytic	NULL
differentiation	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
treatment	NULL
of	NULL
HL-60	NULL
cells	NULL
with	NULL
calcitriol	NULL
is	NULL
associated	NULL
with	NULL
induction	NULL
of	NULL
monocytic	NULL
differentiation	NULL
through	NULL
protein	NULL
kinase	NULL
C-dependent	NULL
signaling	NULL
pathways	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Other	NULL
work	NULL
has	NULL
shown	NULL
that	NULL
the	NULL
c-jun	NULL
and	NULL
c-fms	NULL
genes	NULL
are	NULL
induced	NULL
in	NULL
calcitriol-treated	NULL
HL-60	NULL
cells	NULL
(	NULL
20	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Similar	NULL
findings	NULL
were	NULL
obtained	NULL
in	NULL
the	NULL
present	NULL
studies	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
treatment	NULL
of	NULL
HL-60/vine	NULL
cells	NULL
with	NULL
calcitriol	NULL
had	NULL
little	NULL
if	NULL
any	NULL
effect	NULL
on	NULL
induction	NULL
of	NULL
c-jun	NULL
or	NULL
c-fms	NULL
transcripts	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
there	NULL
was	NULL
no	NULL
evidence	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
phenotypic	NULL
characteristics	NULL
such	NULL
as	NULL
adherence	NULL
or	NULL
growth	NULL
arrest	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
that	NULL
the	NULL
vincristine-selected	NULL
HL-60	NULL
cells	NULL
are	NULL
unresponsive	NULL
to	NULL
TPA	NULL
,	NULL
as	NULL
well	NULL
as	NULL
certain	NULL
other	NULL
inducers	NULL
of	NULL
monocytic	NULL
differentiation	NULL
.	NULL

Recent	NULL
work	NULL
has	NULL
demonstrated	NULL
that	NULL
okadaic	NULL
acid	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
serine/threonine	NULL
protein	NULL
phosphatases	NULL
(	NULL
46	NULL
)	NULL
,	NULL
is	NULL
also	NULL
an	NULL
effective	NULL
inducer	NULL
of	NULL
myeloid	NULL
leukemia	NULL
cell	NULL
differentiation	NULL
(	NULL
47	NULL
,	NULL
48	NULL
)	NULL
.	NULL

Consequently	NULL
,	NULL
we	NULL
sought	NULL
to	NULL
determine	NULL
whether	NULL
HL-60/	NULL
vine	NULL
cells	NULL
would	NULL
respond	NULL
to	NULL
okadaic	NULL
acid	NULL
with	NULL
induction	NULL
of	NULL
c-jun	NULL
expression	NULL
and	NULL
monocytic	NULL
differentiation	NULL
.	NULL

Okadaic	NULL
acid	NULL
treatment	NULL
of	NULL
the	NULL
HL-60/vince	NULL
line	NULL
resulted	NULL
in	NULL
increased	NULL
c-jun	NULL
mRNA	NULL
levels	NULL
,	NULL
which	NULL
were	NULL
detectable	NULL
at	NULL
3	NULL
h	NULL
and	NULL
maximal	NULL
at	NULL
6	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
were	NULL
similar	NULL
to	NULL
the	NULL
level	NULL
of	NULL
c-jun	NULL
expression	NULL
seen	NULL
in	NULL
okadaic	NULL
acid-treated	NULL
parental	NULL
HL-60	NULL
cells	NULL
?	NULL

C.	NULL
A.	NULL
Slapak	NULL
,	NULL
S.	NULL
Kharbanda	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Kufe	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

12269	NULL
L	NULL
6	NULL
&	NULL
S	NULL
Vit	NULL
D	NULL
,	NULL
Q	NULL
Vit	NULL
D	NULL
;	NULL
Lure	NULL
--	NULL
=	NULL
g	NULL
go-	NULL
1	NULL
<	NULL
v	NULL
b	NULL
Â©	NULL
4	NULL
v	NULL
v	NULL
v	NULL
I	NULL
r	NULL
w	NULL
Â®	NULL
I	NULL
-	NULL
ao	NULL
o	NULL
288-w-	NULL
aw	NULL
%	NULL
B	NULL
c-jun	NULL
188-28S-	NULL
--	NULL
sear	NULL
c-fms	NULL
188-	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Effects	NULL
of	NULL
calcitriol	NULL
(	NULL
vitamin	NULL
D	NULL
;	NULL
)	NULL
on	NULL
c-jun	NULL
and	NULL
c-/ms	NULL
expression	NULL
in	NULL
HL-60	NULL
and	NULL
HL-60/vine	NULL
cells	NULL
.	NULL

HL-60	NULL
and	NULL
HL-60/	NULL
vinc	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
0.5	NULL
uM	NULL
calcitriol	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
hybridized	NULL
to	NULL
``	NULL
P-labeled	NULL
c-jun	NULL
and	NULL
c-/ms	NULL
probes	NULL
.	NULL

Ethidium	NULL
bromide	NULL
staining	NULL
of	NULL
the	NULL
gels	NULL
demonstrated	NULL
equal	NULL
loading	NULL
of	NULL
the	NULL
lanes	NULL
.	NULL

A	NULL
.	NULL

B	NULL
>	NULL
oA	NULL
o	NULL
â	NULL
f	NULL
â	NULL
a	NULL
u	NULL
cow	NULL
Â«	NULL
Jor	NULL
Â®	NULL
o	NULL
oo	NULL
I	NULL
-/	NULL
a	NULL
28S	NULL
#	NULL
#	NULL
#	NULL
=	NULL
c-jun	NULL
18S-B	NULL
.	NULL

â¬	NULL
>	NULL
5	NULL
-	NULL
oA	NULL
a	NULL
.IJ	NULL
Â©	NULL
U	NULL
V	NULL
TI	NULL
-	NULL
a	NULL
o	NULL
285-	NULL
P	NULL
c-fms	NULL
18S-	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Okadaic	NULL
acid	NULL
induces	NULL
c-jun	NULL
and	NULL
c-/ms	NULL
expression	NULL
in	NULL
HL-60/vine	NULL
cells	NULL
.	NULL

HL-60/vine	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
40	NULL
ng/ml	NULL
okadaic	NULL
acid	NULL
(	NULL
0A	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
hybridized	NULL
to	NULL
the	NULL
labeled	NULL
c-jun	NULL
(	NULL
A	NULL
)	NULL
and	NULL
c-/ms	NULL
(	NULL
B	NULL
)	NULL
probes	NULL
.	NULL

Ethidium	NULL
bromide	NULL
staining	NULL
of	NULL
the	NULL
gels	NULL
and	NULL
hybridization	NULL
to	NULL
the	NULL
actin	NULL
probe	NULL
demonstrated	NULL
equal	NULL
loading	NULL
of	NULL
the	NULL
lanes	NULL
.	NULL

(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Longer	NULL
exposures	NULL
to	NULL
this	NULL
agent	NULL
were	NULL
associated	NULL
with	NULL
a	NULL
partial	NULL
down-regulation	NULL
of	NULL
c-jun	NULL
transcripts	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

This	NULL
induction	NULL
of	NULL
c-jun	NULL
expression	NULL
by	NULL
okadaic	NULL
acid	NULL
was	NULL
also	NULL
accompanied	NULL
by	NULL
increases	NULL
in	NULL
Â¢c-fms	NULL
transcripts	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
c-fms	NULL
gene	NULL
was	NULL
detectable	NULL
at	NULL
24	NULL
h	NULL
and	NULL
persisted	NULL
for	NULL
at	NULL
least	NULL
72	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
okadaic	NULL
acid	NULL
treatment	NULL
was	NULL
associated	NULL
with	NULL
cessation	NULL
of	NULL
HL-60/vine	NULL
cell	NULL
growth	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
,	NULL
although	NULL
HL-60/vine	NULL
cells	NULL
are	NULL
resistant	NULL
to	NULL
TPA-induced	NULL
differentiation	NULL
,	NULL
this	NULL
variant	NULL
has	NULL
retained	NULL
the	NULL
capacity	NULL
for	NULL
induction	NULL
of	NULL
the	NULL
c-jun	NULL
gene	NULL
and	NULL
other	NULL
characteristics	NULL
of	NULL
the	NULL
differentiated	NULL
monocytic	NULL
phenotype	NULL
.	NULL

In	NULL
order	NULL
to	NULL
define	NULL
in	NULL
greater	NULL
detail	NULL
the	NULL
basis	NULL
for	NULL
these	NULL
different	NULL
responses	NULL
to	NULL
TPA	NULL
and	NULL
okadaic	NULL
acid	NULL
,	NULL
we	NULL
performed	NULL
nuclear	NULL
run-on	NULL
assays	NULL
to	NULL
assess	NULL
transcriptional	NULL
control	NULL
of	NULL
the	NULL
c-jun	NULL
gene	NULL
.	NULL

The	NULL
actin	NULL
gene	NULL
(	NULL
positive	NULL
control	NULL
)	NULL
was	NULL
constitutively	NULL
active	NULL
in	NULL
untreated	NULL
HL-60/vine	NULL
cells	NULL
and	NULL
similar	NULL
transcription	NULL
rates	NULL
were	NULL
obtained	NULL
after	NULL
treatment	NULL
with	NULL
TPA	NULL
or	NULL
okadaic	NULL
acid	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

A	NULL
low	NULL
level	NULL
of	NULL
c-jun	NULL
gene	NULL
transcription	NULL
was	NULL
present	NULL
in	NULL
the	NULL
HL-60/vince	NULL
line	NULL
,	NULL
and	NULL
,	NULL
although	NULL
this	NULL
gene	NULL
is	NULL
induced	NULL
(	NULL
2-3-fold	NULL
)	NULL
in	NULL
TPA-treated	NULL
HL-60	NULL
cells	NULL
(	NULL
20	NULL
)	NULL
,	NULL
TPA	NULL
12270	NULL
actin	NULL
c-jun	NULL
Control	NULL
TPA	NULL
OA	NULL
kb	NULL
Fic	NULL
.	NULL

4.	NULL
c-jun	NULL
transcription	NULL
is	NULL
activated	NULL
by	NULL
okadaic	NULL
acid	NULL
and	NULL
not	NULL
TPA	NULL
.	NULL

HL-60/vine	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
32	NULL
nM	NULL
TPA	NULL
or	NULL
40	NULL
ng/	NULL
ml	NULL
okadaic	NULL
acid	NULL
for	NULL
6	NULL
h.	NULL
Nuclei	NULL
were	NULL
isolated	NULL
and	NULL
newly	NULL
elongated	NULL
P-labeled	NULL
RNA	NULL
transcripts	NULL
were	NULL
hybridized	NULL
to	NULL
2	NULL
ug	NULL
of	NULL
actin	NULL
or	NULL
c-jun	NULL
inserts	NULL
after	NULL
restriction	NULL
enzyme	NULL
digestion	NULL
and	NULL
Southern	NULL
blotting	NULL
.	NULL

The	NULL
solid	NULL
lines	NULL
in	NULL
the	NULL
schematic	NULL
represent	NULL
the	NULL
relative	NULL
position	NULL
of	NULL
the	NULL
DNA	NULL
inserts	NULL
.	NULL

&	NULL
C	NULL
E	NULL
>	NULL
TPA	NULL
@	NULL
m	NULL
--	NULL
--	NULL
--	NULL
?	NULL

â¬	NULL
c	NULL
c	NULL
coc	NULL
al	NULL
--	NULL
-28s	NULL
pay	NULL
f	NULL
f	NULL
|	NULL
L	NULL
(	NULL
$	NULL
&	NULL
Â§	NULL
#	NULL
#	NULL
#	NULL
Â¢jun	NULL
28S-	NULL
4	NULL
188-	NULL
_-	NULL
w	NULL
Â»	NULL
&	NULL
@	NULL
@	NULL
Â«	NULL
)	NULL
U	NULL
``	NULL
~B	NULL
2885-	NULL
b	NULL
;	NULL
P	NULL
c-fos	NULL
28S-	NULL
*	NULL
fos-B	NULL
18s-198=	NULL
ees	NULL
Â»	NULL
fra-	NULL
1	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Effects	NULL
of	NULL
TPA	NULL
on	NULL
c-jun	NULL
,	NULL
jun-B	NULL
,	NULL
c-fos	NULL
,	NULL
fos-	NULL
B	NULL
,	NULL
and	NULL
fra-1	NULL
expression	NULL
in	NULL
HL-60/vine/R	NULL
cells	NULL
.	NULL

HL-60/vinc/R	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
32	NULL
nm	NULL
TPA	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
hybridized	NULL
to	NULL
the	NULL
c-jun	NULL
,	NULL
jun-B	NULL
,	NULL
c-fos	NULL
,	NULL
fos-B	NULL
,	NULL
and	NULL
fra-1	NULL
probes	NULL
.	NULL

Ethidium	NULL
bromide	NULL
staining	NULL
of	NULL
the	NULL
gels	NULL
demonstrated	NULL
equal	NULL
loading	NULL
of	NULL
the	NULL
lanes	NULL
.	NULL

had	NULL
little	NULL
effect	NULL
on	NULL
the	NULL
rate	NULL
of	NULL
c-jun	NULL
transcription	NULL
in	NULL
the	NULL
vincristine-resistant	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
okadaic	NULL
acid	NULL
treatment	NULL
was	NULL
associated	NULL
with	NULL
an	NULL
8-fold	NULL
stimulation	NULL
of	NULL
c-jun	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
HL-60/	NULL
vince	NULL
cells	NULL
are	NULL
defective	NULL
in	NULL
TPA-induced	NULL
signaling	NULL
events	NULL
that	NULL
confer	NULL
inducibility	NULL
of	NULL
the	NULL
c-jun	NULL
gene	NULL
and	NULL
that	NULL
these	NULL
events	NULL
may	NULL
involve	NULL
serine/threonine	NULL
protein	NULL
phosphorylation	NULL
.	NULL

The	NULL
present	NULL
results	NULL
thus	NULL
indicate	NULL
that	NULL
selection	NULL
for	NULL
vincristine	NULL
resistance	NULL
is	NULL
associated	NULL
with	NULL
loss	NULL
of	NULL
HL-60	NULL
cells	NULL
to	NULL
undergo	NULL
TPA-induced	NULL
monocytic	NULL
differentiation	NULL
.	NULL

This	NULL
issue	NULL
was	NULL
addressed	NULL
in	NULL
greater	NULL
detail	NULL
using	NULL
a	NULL
revertant	NULL
of	NULL
the	NULL
HL-60/vinc	NULL
line	NULL
,	NULL
designated	NULL
HL-60/vinc/R	NULL
,	NULL
which	NULL
has	NULL
regained	NULL
partial	NULL
sensitivity	NULL
to	NULL
the	NULL
cytotoxic	NULL
effects	NULL
of	NULL
vincristine	NULL
(	NULL
30	NULL
)	NULL
.	NULL

The	NULL
response	NULL
of	NULL
HL-60/vinc/R	NULL
cells	NULL
to	NULL
TPA	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
HL-60/vince	NULL
cells	NULL
in	NULL
that	NULL
there	NULL
was	NULL
little	NULL
effect	NULL
of	NULL
this	NULL
agent	NULL
on	NULL
c-jun	NULL
or	NULL
fos-B	NULL
mRNA	NULL
levels	NULL
in	NULL
either	NULL
line	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
HL-60/vinc/R	NULL
cells	NULL
responded	NULL
to	NULL
TPA	NULL
with	NULL
an	NULL
increase	NULL
in	NULL
jun-B	NULL
and	NULL
fra-1	NULL
mRNA	NULL
which	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
in	NULL
both	NULL
HL-60	NULL
and	NULL
HL-60/vine	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
and	NULL
Ref	NULL
.	NULL

27	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
c-fos	NULL
expression	NULL
was	NULL
increased	NULL
in	NULL
TPA-treated	NULL
HL-60/vinc/R	NULL
cells	NULL
compared	NULL
with	NULL
the	NULL
HL-60/vine	NULL
line	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

TPA	NULL
treatment	NULL
of	NULL
HL-60/vinc/R	NULL
cells	NULL
was	NULL
also	NULL
associated	NULL
Vincristine	NULL
Resistance	NULL
Blocks	NULL
TPA-mediated	NULL
Signaling	NULL
Events	NULL
with	NULL
inhibition	NULL
of	NULL
growth	NULL
,	NULL
adherence	NULL
,	NULL
and	NULL
increases	NULL
in	NULL
Macl	NULL
expression	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
HL-60/vinc/R	NULL
cells	NULL
responded	NULL
to	NULL
TPA	NULL
with	NULL
increases	NULL
in	NULL
TNF	NULL
and	NULL
c-fms	NULL
gene	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
demonstrate	NULL
that	NULL
the	NULL
HL-60/vinc/R	NULL
line	NULL
has	NULL
regained	NULL
the	NULL
capacity	NULL
to	NULL
undergo	NULL
TPA-induced	NULL
monocytic	NULL
differentiation	NULL
.	NULL

TPA	NULL
activates	NULL
isozymes	NULL
of	NULL
the	NULL
serine/threonine	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
family	NULL
(	NULL
49	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
HL-60/vine	NULL
and	NULL
HL-60/vinc/R	NULL
cells	NULL
differ	NULL
in	NULL
their	NULL
response	NULL
to	NULL
TPA	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
effects	NULL
of	NULL
this	NULL
agent	NULL
on	NULL
PKC	NULL
activation	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Translocation	NULL
of	NULL
PKC	NULL
from	NULL
the	NULL
cytosol	NULL
to	NULL
membranes	NULL
was	NULL
measured	NULL
using	NULL
a	NULL
synthetic	NULL
PKC-specific	NULL
substrate	NULL
derived	NULL
from	NULL
myelin	NULL
basic	NULL
protein	NULL
(	NULL
MBP	NULL
)	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Using	NULL
this	NULL
approach	NULL
,	NULL
treatment	NULL
of	NULL
HL-60	NULL
cells	NULL
with	NULL
TPA	NULL
was	NULL
associated	NULL
with	NULL
a	NULL
decline	NULL
in	NULL
cytosolic	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
and	NULL
a	NULL
concomitant	NULL
increase	NULL
in	NULL
membrane-bound	NULL
PKC	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

Although	NULL
similar	NULL
levels	NULL
of	NULL
basal	NULL
PKC	NULL
activity	NULL
were	NULL
present	NULL
in	NULL
HL-60/vine	NULL
cells	NULL
,	NULL
there	NULL
was	NULL
no	NULL
evidence	NULL
of	NULL
translocation	NULL
during	NULL
TPA	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
HL-60/vine	NULL
cells	NULL
,	NULL
TPA	NULL
treatment	NULL
of	NULL
the	NULL
HL-60/vinc/R	NULL
line	NULL
was	NULL
associated	NULL
with	NULL
translocation	NULL
of	NULL
PKC	NULL
activity	NULL
from	NULL
the	NULL
cytosol	NULL
to	NULL
the	NULL
membrane	NULL
fraction	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
indicate	NULL
that	NULL
the	NULL
c-Jun	NULL
protein	NULL
is	NULL
phosphoryl-ated	NULL
on	NULL
serine/threonine	NULL
residues	NULL
by	NULL
kinases	NULL
of	NULL
the	NULL
MAP	NULL
family	NULL
(	NULL
44	NULL
)	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
phorbol	NULL
ester-induced	NULL
activation	NULL
of	NULL
c-jun	NULL
in	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
appears	NULL
to	NULL
involve	NULL
MAP	NULL
kinase-dependent	NULL
pathways	NULL
(	NULL
44	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
if	NULL
defects	NULL
in	NULL
MAP	NULL
kinase	NULL
signaling	NULL
pathways	NULL
were	NULL
present	NULL
in	NULL
HL-60/vine	NULL
cells	NULL
,	NULL
we	NULL
first	NULL
monitored	NULL
cytosolic	NULL
extracts	NULL
for	NULL
MAP	NULL
kinase	NULL
activity	NULL
in	NULL
an	NULL
assay	NULL
utilizing	NULL
MBP	NULL
as	NULL
a	NULL
substrate	NULL
.	NULL

After	NULL
exposure	NULL
to	NULL
TPA	NULL
for	NULL
30	NULL
min	NULL
or	NULL
okadaic	NULL
acid	NULL
for	NULL
3	NULL
h	NULL
,	NULL
HL-60	NULL
cells	NULL
showed	NULL
a	NULL
marked	NULL
increase	NULL
in	NULL
MAP	NULL
kinase	NULL
activity	NULL
as	NULL
demonstrated	NULL
by	NULL
more	NULL
than	NULL
a	NULL
doubling	NULL
in	NULL
MBP	NULL
phosphorylation	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
HL-60/vine	NULL
cells	NULL
had	NULL
no	NULL
detectable	NULL
increase	NULL
in	NULL
MAP	NULL
kinase	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
TPA	NULL
,	NULL
but	NULL
did	NULL
respond	NULL
to	NULL
okadaic	NULL
acid	NULL
in	NULL
a	NULL
manner	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
parental	NULL
cell	NULL
line	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
this	NULL
difference	NULL
in	NULL
kinase	NULL
activity	NULL
resulted	NULL
in	NULL
increased	NULL
phosphorylation	NULL
of	NULL
c-Jun	NULL
,	NULL
a	NULL
synthetic	NULL
Y-peptide	NULL
including	NULL
serine	NULL
residues	NULL
57	NULL
and	NULL
62	NULL
on	NULL
c-Jun	NULL
was	NULL
utilized	NULL
as	NULL
a	NULL
substrate	NULL
in	NULL
the	NULL
MAP	NULL
kinase	NULL
assay	NULL
(	NULL
44	NULL
)	NULL
.	NULL

HL-60	NULL
cells	NULL
responded	NULL
to	NULL
both	NULL
TPA	NULL
and	NULL
okadaic	NULL
acid	NULL
with	NULL
an	NULL
increase	NULL
(	NULL
>	NULL
2-fold	NULL
)	NULL
in	NULL
phosphorylation	NULL
of	NULL
Y-peptide	NULL
.	NULL

However	NULL
,	NULL
although	NULL
no	NULL
increase	NULL
in	NULL
Y-peptide	NULL
phos-	NULL
&	NULL
A	NULL
.	NULL

S	NULL
Â£	NULL
&	NULL
TPA	NULL
@	NULL
=	NULL
--	NULL
--	NULL
-	NULL
l	NULL
â	NULL
f	NULL
so	NULL
go	NULL
&	NULL
$	NULL
7	NULL
f	NULL
%	NULL
28S-TNF	NULL
18s-	NULL
_	NULL
``	NULL
*	NULL
@	NULL
Â®	NULL
&	NULL
B	NULL
.	NULL

S	NULL
&	NULL
8	NULL
-	NULL
TPA	NULL
#	NULL
--	NULL
-4	NULL
v	NULL
v	NULL
v	NULL
x	NULL
-	NULL
8	NULL
Â®	NULL
28S-	NULL
_	NULL
up	NULL
ap	NULL
Â«	NULL
c-fms	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

TPA	NULL
induces	NULL
TNF	NULL
and	NULL
c-/ms	NULL
expression	NULL
in	NULL
HL-60/	NULL
vinc/R	NULL
cells	NULL
.	NULL

HL-60/vinc/R	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
32	NULL
nm	NULL
TPA	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
hybridized	NULL
to	NULL
the	NULL
TNF	NULL
and	NULL
c-fms	NULL
probes	NULL
.	NULL

Vincristine	NULL
Resistance	NULL
Blocks	NULL
TPA-mediated	NULL
Signaling	NULL
Events	NULL
A.	NULL
CYTOSOL	NULL
1000	NULL
~	NULL
-	NULL
800	NULL
&	NULL
E	NULL
3	NULL
e	NULL
soo	NULL
P	NULL
Control	NULL
4	NULL
E	NULL
5/7	NULL
TPA	NULL
,	NULL
30Â°	NULL
-	NULL
P	NULL
b	NULL
,	NULL
g	NULL
â	NULL
;	NULL
400	NULL
2g	NULL
?	NULL

U	NULL
TPA	NULL
,	NULL
so	NULL
&	NULL
-	NULL
2oo	NULL
Ã©	NULL
%	NULL
/	NULL
8	NULL
,	NULL
|	NULL
#	NULL
4	NULL
#	NULL
PB	NULL
HL-60	NULL
HL-60/vinec	NULL
_	NULL
HL-60/vine/R	NULL
B.	NULL
MEMBRANE	NULL
1000	NULL
_	NULL
-	NULL
800	NULL
>	NULL
â¬	NULL
E	NULL
E	NULL
600	NULL
Control	NULL
<	NULL
E	NULL
TPA	NULL
,	NULL
30	NULL
Qo	NULL
*	NULL
``	NULL
LZ	NULL
J	NULL
TPA	NULL
so	NULL
a	NULL
E	NULL
7	NULL
&	NULL
200	NULL
HL-60/vinÃ©	NULL
HL-60/vinc/R	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

Effects	NULL
of	NULL
TPA	NULL
on	NULL
translocation	NULL
of	NULL
PKC	NULL
activity	NULL
.	NULL

HL-60	NULL
,	NULL
HL-60/vinc	NULL
,	NULL
and	NULL
HL-60/vinc/R	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
32	NULL
nM	NULL
TPA	NULL
.	NULL

PKC	NULL
activity	NULL
was	NULL
determined	NULL
in	NULL
the	NULL
cytosol	NULL
(	NULL
A4	NULL
)	NULL
and	NULL
membrane	NULL
(	NULL
B	NULL
)	NULL
fractions	NULL
.	NULL

Samples	NULL
were	NULL
assayed	NULL
from	NULL
control	NULL
cells	NULL
and	NULL
after	NULL
treatment	NULL
with	NULL
TPA	NULL
for	NULL
30	NULL
and	NULL
60	NULL
min	NULL
.	NULL

Results	NULL
(	NULL
pmol/min/mg	NULL
protein	NULL
)	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
S.E	NULL
.	NULL

of	NULL
three	NULL
determinations	NULL
each	NULL
performed	NULL
in	NULL
duplicate	NULL
.	NULL

phorylation	NULL
was	NULL
observed	NULL
during	NULL
treatment	NULL
of	NULL
HL-60/vine	NULL
cells	NULL
with	NULL
TPA	NULL
,	NULL
okadaic	NULL
acid	NULL
stimulation	NULL
resulted	NULL
in	NULL
similar	NULL
levels	NULL
of	NULL
this	NULL
kinase	NULL
activity	NULL
as	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
the	NULL
parental	NULL
cell	NULL
line	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

DISCUSSION	NULL
Drug-resistant	NULL
human	NULL
and	NULL
murine	NULL
leukemia	NULL
cell	NULL
lines	NULL
have	NULL
been	NULL
studied	NULL
previously	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
differentiate	NULL
in	NULL
response	NULL
to	NULL
various	NULL
inducing	NULL
agents	NULL
.	NULL

The	NULL
results	NULL
have	NULL
in	NULL
general	NULL
demonstrated	NULL
little	NULL
difference	NULL
in	NULL
induction	NULL
of	NULL
a	NULL
differentiated	NULL
phenotype	NULL
as	NULL
compared	NULL
with	NULL
drug-sensitive	NULL
parental	NULL
cell	NULL
lines	NULL
(	NULL
50-53	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
multidrug-resistant	NULL
HL-60	NULL
cells	NULL
(	NULL
HL-60/AR	NULL
)	NULL
selected	NULL
in	NULL
increasing	NULL
concentrations	NULL
of	NULL
doxorubicin	NULL
respond	NULL
to	NULL
TPA	NULL
with	NULL
growth	NULL
inhibition	NULL
and	NULL
adherence	NULL
(	NULL
50	NULL
)	NULL
.	NULL

The	NULL
HL-60/AR	NULL
cells	NULL
also	NULL
differentiate	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
dimethyl	NULL
sulfoxide	NULL
(	NULL
51	NULL
)	NULL
.	NULL

Other	NULL
studies	NULL
in	NULL
anthra-cycline-resistant	NULL
murine	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
have	NULL
similarly	NULL
demonstrated	NULL
responsiveness	NULL
to	NULL
various	NULL
inducers	NULL
of	NULL
differentiation	NULL
(	NULL
52	NULL
)	NULL
.	NULL

One	NULL
exception	NULL
,	NULL
however	NULL
,	NULL
is	NULL
a	NULL
vincristine-selected	NULL
murine	NULL
erythroleukemia	NULL
(	NULL
MEL	NULL
)	NULL
cell	NULL
line	NULL
that	NULL
exhibits	NULL
enhanced	NULL
susceptibility	NULL
to	NULL
hexamethylene	NULL
bisacetamide	NULL
(	NULL
HMBA	NULL
)	NULL
-induced	NULL
differentiation	NULL
(	NULL
54	NULL
)	NULL
.	NULL

This	NULL
increase	NULL
in	NULL
HMBA	NULL
sensitivity	NULL
has	NULL
been	NULL
attributed	NULL
to	NULL
elevated	NULL
levels	NULL
of	NULL
PKC-8	NULL
(	NULL
55	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
this	NULL
cell	NULL
line	NULL
fails	NULL
to	NULL
respond	NULL
to	NULL
TPA	NULL
as	NULL
an	NULL
inhibitor	NULL
of	NULL
HMBA-induced	NULL
differentiation	NULL
.	NULL

The	NULL
present	NULL
studies	NULL
were	NULL
performed	NULL
on	NULL
two	NULL
multidrug-resistant	NULL
HL-60	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
HL-60/vine	NULL
cells	NULL
constitutively	NULL
12271	NULL
HL-60	NULL
300	NULL
F	NULL
>	NULL
Â§	NULL
200	NULL
;	NULL
0	NULL
I~	NULL
MBP	NULL
0	NULL
<	NULL
Y-PEPTIDE	NULL
c	NULL
Â§Â§	NULL
100	NULL
5	NULL
Â®	NULL
z	NULL
&	NULL
0	NULL
HL-60/vinc	NULL
p	NULL
>	NULL
Â§	NULL
;	NULL
0	NULL
I	NULL
+	NULL
MBP	NULL
o	NULL
<	NULL
~	NULL
Y-PEPTIDE	NULL
t	NULL
5	NULL
#	NULL
o	NULL
5	NULL
o	NULL
x	NULL
&	NULL
TPA	NULL
OA	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

Effects	NULL
of	NULL
TPA	NULL
and	NULL
okadaic	NULL
acid	NULL
(	NULL
04A	NULL
)	NULL
on	NULL
MAP	NULL
kinase	NULL
activity	NULL
in	NULL
HL-60	NULL
and	NULL
HL-60/vine	NULL
cells	NULL
.	NULL

MAP	NULL
kinase	NULL
activity	NULL
was	NULL
determined	NULL
in	NULL
cytosolic	NULL
fractions	NULL
of	NULL
cells	NULL
treated	NULL
with	NULL
either	NULL
32	NULL
nM	NULL
TPA	NULL
for	NULL
30	NULL
min	NULL
or	NULL
40	NULL
ng/ml	NULL
okadaic	NULL
acid	NULL
for	NULL
3	NULL
h.	NULL
MAP	NULL
kinase	NULL
activity	NULL
was	NULL
assayed	NULL
using	NULL
either	NULL
MBP	NULL
or	NULL
Y-peptide	NULL
as	NULL
sub-strates	NULL
.	NULL

The	NULL
results	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
S.E	NULL
.	NULL

of	NULL
three	NULL
experiments	NULL
and	NULL
are	NULL
expressed	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
that	NULL
obtained	NULL
in	NULL
unstimulated	NULL
cells	NULL
.	NULL

The	NULL
absolute	NULL
kinase	NULL
activity	NULL
values	NULL
for	NULL
HL-60	NULL
and	NULL
HL-60/vine	NULL
cells	NULL
were	NULL
110	NULL
+	NULL
19	NULL
and	NULL
83	NULL
+	NULL
11	NULL
pmol/min/mg	NULL
protein	NULL
respectively	NULL
.	NULL

In	NULL
each	NULL
experiment	NULL
,	NULL
background	NULL
phosphorylation	NULL
,	NULL
measured	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
cytosolic	NULL
extract	NULL
,	NULL
was	NULL
less	NULL
than	NULL
5	NULL
%	NULL
.	NULL

express	NULL
high	NULL
levels	NULL
of	NULL
P-glycoprotein	NULL
,	NULL
whereas	NULL
expression	NULL
of	NULL
this	NULL
transporter	NULL
in	NULL
a	NULL
partial	NULL
revertant	NULL
line	NULL
,	NULL
designated	NULL
HL-60/	NULL
vinc/R	NULL
,	NULL
is	NULL
diminished	NULL
by	NULL
over	NULL
95	NULL
%	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Immunophenotyping	NULL
studies	NULL
of	NULL
HL-60	NULL
,	NULL
HL-60/vinc	NULL
,	NULL
and	NULL
HL-60/vinc/R	NULL
failed	NULL
to	NULL
detect	NULL
differences	NULL
in	NULL
the	NULL
baseline	NULL
expression	NULL
of	NULL
myeloid	NULL
or	NULL
monocytic	NULL
differentiation	NULL
antigens	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
HL-60/vine	NULL
and	NULL
HL-60/vinc/R	NULL
appear	NULL
to	NULL
be	NULL
at	NULL
the	NULL
same	NULL
relatively	NULL
undifferentiated	NULL
state	NULL
as	NULL
HL-60	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
when	NULL
treated	NULL
with	NULL
TPA	NULL
,	NULL
the	NULL
HL-60/vinc	NULL
cells	NULL
fail	NULL
to	NULL
undergo	NULL
phenotypic	NULL
changes	NULL
such	NULL
as	NULL
growth	NULL
inhibition	NULL
,	NULL
adherence	NULL
,	NULL
and	NULL
increases	NULL
in	NULL
Macl	NULL
expression	NULL
associated	NULL
with	NULL
TPA-induced	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
.	NULL

Treatment	NULL
with	NULL
calcitriol	NULL
similarly	NULL
failed	NULL
to	NULL
induce	NULL
a	NULL
monocytic	NULL
phenotype	NULL
in	NULL
the	NULL
HL-60/	NULL
vinc	NULL
cell	NULL
line	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
such	NULL
phenotypic	NULL
changes	NULL
,	NULL
as	NULL
well	NULL
as	NULL
induction	NULL
of	NULL
the	NULL
TNF	NULL
and	NULL
c-fms	NULL
genes	NULL
,	NULL
occur	NULL
in	NULL
TPA-treated	NULL
HL-60/vinc/R	NULL
cells	NULL
suggested	NULL
that	NULL
insensitivity	NULL
to	NULL
differentiation	NULL
by	NULL
TPA	NULL
in	NULL
the	NULL
HL-60/vinc	NULL
line	NULL
was	NULL
reversible	NULL
and	NULL
related	NULL
in	NULL
some	NULL
way	NULL
to	NULL
the	NULL
drug-resistant	NULL
phenotype	NULL
.	NULL

These	NULL
findings	NULL
are	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
conversion	NULL
of	NULL
differentiation	NULL
inducer	NULL
insensitivity	NULL
to	NULL
sensitivity	NULL
with	NULL
the	NULL
development	NULL
of	NULL
vincristine-selected	NULL
,	NULL
multidrug	NULL
resistance	NULL
in	NULL
MEL	NULL
cells	NULL
(	NULL
56	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
TPA-induced	NULL
monocytic	NULL
differentiation	NULL
of	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
is	NULL
associated	NULL
12272	NULL
with	NULL
activation	NULL
of	NULL
jun/fos	NULL
gene	NULL
expression	NULL
(	NULL
20-23	NULL
)	NULL
.	NULL

The	NULL
present	NULL
findings	NULL
demonstrate	NULL
that	NULL
HL-60/vine	NULL
cells	NULL
fail	NULL
to	NULL
respond	NULL
to	NULL
TPA	NULL
or	NULL
calcitriol	NULL
with	NULL
an	NULL
increase	NULL
in	NULL
c-jun	NULL
transcripts	NULL
.	NULL

The	NULL
findings	NULL
also	NULL
suggest	NULL
that	NULL
induction	NULL
of	NULL
c-jun	NULL
expression	NULL
is	NULL
not	NULL
obligatory	NULL
for	NULL
TPA-induced	NULL
monocytic	NULL
differentiation	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
there	NULL
was	NULL
little	NULL
if	NULL
any	NULL
increase	NULL
in	NULL
c-jun	NULL
expression	NULL
in	NULL
association	NULL
with	NULL
TPA-induced	NULL
differentiation	NULL
of	NULL
the	NULL
HL-60/	NULL
vinc/R	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
finding	NULL
that	NULL
jun-B	NULL
and	NULL
fra-1	NULL
are	NULL
induced	NULL
in	NULL
TPA-treated	NULL
HL-60/vine	NULL
cells	NULL
,	NULL
which	NULL
fail	NULL
to	NULL
express	NULL
the	NULL
mature	NULL
phenotype	NULL
,	NULL
suggests	NULL
that	NULL
jun-B	NULL
or	NULL
fra-1	NULL
expression	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
induction	NULL
of	NULL
differentiation	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
although	NULL
there	NULL
was	NULL
little	NULL
induction	NULL
of	NULL
c-fos	NULL
transcripts	NULL
in	NULL
TPA-treated	NULL
HL-60/vinc	NULL
cells	NULL
,	NULL
differentiation	NULL
of	NULL
the	NULL
HL-60/vinc/R	NULL
line	NULL
with	NULL
TPA	NULL
was	NULL
associated	NULL
with	NULL
increases	NULL
in	NULL
c-fos	NULL
expression	NULL
.	NULL

Jun-B	NULL
functions	NULL
as	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
genes	NULL
activated	NULL
by	NULL
c-Jun	NULL
(	NULL
57	NULL
,	NULL
58	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
formation	NULL
of	NULL
Jun-B/c-Fos	NULL
heterodimers	NULL
results	NULL
in	NULL
more	NULL
efficient	NULL
binding	NULL
to	NULL
the	NULL
TRE	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
coexpression	NULL
of	NULL
Jun-B	NULL
and	NULL
c-Fos	NULL
might	NULL
be	NULL
necessary	NULL
at	NULL
least	NULL
in	NULL
part	NULL
for	NULL
TPA-induced	NULL
differentiation	NULL
in	NULL
these	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
.	NULL

Other	NULL
studies	NULL
have	NULL
described	NULL
HL-60	NULL
cells	NULL
that	NULL
are	NULL
resistant	NULL
to	NULL
TPA-induced	NULL
differentiation	NULL
.	NULL

The	NULL
HL-525	NULL
subline	NULL
was	NULL
selected	NULL
in	NULL
increasing	NULL
concentrations	NULL
of	NULL
phorbol	NULL
esters	NULL
and	NULL
fails	NULL
to	NULL
respond	NULL
to	NULL
TPA	NULL
with	NULL
induction	NULL
of	NULL
monocytic	NULL
differentiation	NULL
(	NULL
59	NULL
)	NULL
.	NULL

These	NULL
cells	NULL
also	NULL
fail	NULL
to	NULL
respond	NULL
to	NULL
TPA	NULL
with	NULL
induction	NULL
of	NULL
c-jun	NULL
and	NULL
c-fos	NULL
expression	NULL
(	NULL
60	NULL
)	NULL
.	NULL

However	NULL
,	NULL
treatment	NULL
of	NULL
HL-525	NULL
cells	NULL
with	NULL
calcitriol	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
monocytic	NULL
phenotype	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
increases	NULL
in	NULL
c-fos	NULL
transcripts	NULL
(	NULL
61	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
jun-B	NULL
gene	NULL
expression	NULL
is	NULL
attenuated	NULL
in	NULL
TPA-treated	NULL
HL-525	NULL
cells	NULL
(	NULL
62	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
with	NULL
jun-B	NULL
and	NULL
the	NULL
sensitivity	NULL
to	NULL
calcitriol	NULL
indicate	NULL
that	NULL
the	NULL
signaling	NULL
defects	NULL
in	NULL
HL-525	NULL
cells	NULL
are	NULL
at	NULL
least	NULL
in	NULL
part	NULL
different	NULL
from	NULL
those	NULL
in	NULL
HL-60/vine	NULL
cells	NULL
.	NULL

Another	NULL
cell	NULL
line	NULL
,	NULL
designated	NULL
HL-60R	NULL
,	NULL
was	NULL
similarly	NULL
developed	NULL
by	NULL
prolonged	NULL
exposure	NULL
to	NULL
TPA	NULL
,	NULL
but	NULL
is	NULL
unresponsive	NULL
to	NULL
both	NULL
TPA	NULL
and	NULL
calcitriol	NULL
(	NULL
63	NULL
)	NULL
.	NULL

The	NULL
HL-525	NULL
and	NULL
HL-6O0R	NULL
lines	NULL
exhibit	NULL
altered	NULL
expression	NULL
of	NULL
PKC	NULL
isozymes	NULL
(	NULL
60	NULL
,	NULL
62	NULL
,	NULL
63	NULL
)	NULL
,	NULL
although	NULL
the	NULL
precise	NULL
defect	NULL
responsible	NULL
for	NULL
TPA	NULL
insensitivity	NULL
in	NULL
these	NULL
cells	NULL
remains	NULL
unclear	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
PKC-a	NULL
Â«	NULL
and	NULL
PKC-8	NULL
genes	NULL
is	NULL
similar	NULL
in	NULL
HL-60/vine	NULL
as	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
parental	NULL
HL-60	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
basis	NULL
for	NULL
insensitivity	NULL
to	NULL
TPA-induced	NULL
differentiation	NULL
in	NULL
vincristine-resistant	NULL
HL-60	NULL
cells	NULL
appears	NULL
to	NULL
be	NULL
different	NULL
from	NULL
that	NULL
associated	NULL
with	NULL
sublines	NULL
selected	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
phorbol	NULL
esters	NULL
.	NULL

Although	NULL
certain	NULL
insights	NULL
regarding	NULL
the	NULL
role	NULL
of	NULL
early	NULL
response	NULL
gene	NULL
expression	NULL
in	NULL
monocytic	NULL
differentiation	NULL
can	NULL
be	NULL
derived	NULL
from	NULL
studying	NULL
the	NULL
HL-60/vine	NULL
and	NULL
HL-60/vinc/R	NULL
cells	NULL
,	NULL
we	NULL
were	NULL
interested	NULL
in	NULL
determining	NULL
potential	NULL
upstream	NULL
signaling	NULL
defects	NULL
associated	NULL
with	NULL
TPA	NULL
resistance	NULL
.	NULL

One	NULL
effect	NULL
of	NULL
TPA	NULL
is	NULL
the	NULL
activation	NULL
of	NULL
PKC	NULL
with	NULL
translocation	NULL
of	NULL
isozymes	NULL
from	NULL
the	NULL
cytosol	NULL
to	NULL
membrane	NULL
fractions	NULL
(	NULL
49	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
this	NULL
enzyme	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
necessary	NULL
for	NULL
TPA-induced	NULL
monocytic	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
(	NULL
59	NULL
,	NULL
64	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
PKC	NULL
,	NULL
as	NULL
well	NULL
as	NULL
other	NULL
protein	NULL
kinases	NULL
,	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
important	NULL
modulators	NULL
of	NULL
P-glycoprotein	NULL
function	NULL
(	NULL
65	NULL
,	NULL
66	NULL
)	NULL
.	NULL

When	NULL
examined	NULL
for	NULL
baseline	NULL
expression	NULL
,	NULL
HL-60	NULL
,	NULL
HL-60/vinc	NULL
,	NULL
and	NULL
HL-60/vinc/R	NULL
cells	NULL
showed	NULL
no	NULL
significant	NULL
differences	NULL
in	NULL
PKC	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
although	NULL
PKC	NULL
activation	NULL
was	NULL
detectable	NULL
in	NULL
both	NULL
HL-60	NULL
and	NULL
HL-60/vinc/R	NULL
cells	NULL
,	NULL
there	NULL
was	NULL
no	NULL
evidence	NULL
for	NULL
translocation	NULL
in	NULL
the	NULL
HL-60/vine	NULL
line	NULL
.	NULL

The	NULL
present	NULL
results	NULL
demonstrate	NULL
that	NULL
defects	NULL
in	NULL
TPA-induced	NULL
signaling	NULL
in	NULL
HL-60/vine	NULL
cells	NULL
also	NULL
involve	NULL
the	NULL
MAP	NULL
kinase	NULL
family	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
TPA	NULL
had	NULL
little	NULL
effect	NULL
on	NULL
phosphorylation	NULL
of	NULL
MBP	NULL
and	NULL
the	NULL
c-Jun	NULL
Y-peptide	NULL
in	NULL
HL-60/vine	NULL
cells	NULL
,	NULL
whereas	NULL
okadaic	NULL
acid	NULL
bypassed	NULL
this	NULL
defect	NULL
.	NULL

Indeed	NULL
,	NULL
okadaic	NULL
acid	NULL
treatment	NULL
was	NULL
associated	NULL
with	NULL
activation	NULL
of	NULL
MAP	NULL
Vincristine	NULL
Resistance	NULL
Blocks	NULL
TPA-mediated	NULL
Signaling	NULL
Events	NULL
kinase	NULL
,	NULL
phosphorylation	NULL
of	NULL
c-Jun	NULL
Y-peptide	NULL
and	NULL
induction	NULL
of	NULL
monocytic	NULL
differentiation	NULL
in	NULL
the	NULL
TPA-unresponsive	NULL
HL-60/	NULL
vine	NULL
cells	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
HL-60/vinec	NULL
cells	NULL
are	NULL
defective	NULL
in	NULL
early	NULL
TPA-induced	NULL
signaling	NULL
events	NULL
such	NULL
as	NULL
translocation	NULL
of	NULL
PKC	NULL
from	NULL
the	NULL
cytosol	NULL
to	NULL
the	NULL
membrane	NULL
and	NULL
subsequent	NULL
serine/threonine	NULL
phosphorylation	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
other	NULL
events	NULL
,	NULL
such	NULL
as	NULL
induction	NULL
of	NULL
jun-B	NULL
or	NULL
fra-1	NULL
expression	NULL
,	NULL
would	NULL
appear	NULL
to	NULL
be	NULL
independent	NULL
of	NULL
redistributing	NULL
PKC	NULL
activity	NULL
from	NULL
the	NULL
cytosol	NULL
to	NULL
membrane	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
PKC	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
translocate	NULL
from	NULL
the	NULL
cytosol	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
67	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
signaling	NULL
defects	NULL
in	NULL
HL-60/vine	NULL
cells	NULL
may	NULL
be	NULL
related	NULL
to	NULL
overexpression	NULL
of	NULL
P-glycoprotein	NULL
,	NULL
doxorubicin-se-lected	NULL
multidrug-resistant	NULL
HL-60	NULL
cells	NULL
differentiate	NULL
in	NULL
response	NULL
to	NULL
TPA	NULL
.	NULL

Additionally	NULL
,	NULL
vincristine-resistant	NULL
MEL	NULL
cells	NULL
are	NULL
insensitive	NULL
to	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
phorbol	NULL
esters	NULL
on	NULL
HMBA-induced	NULL
differentiation	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
present	NULL
findings	NULL
may	NULL
be	NULL
related	NULL
to	NULL
resistance	NULL
mechanisms	NULL
specific	NULL
to	NULL
vincristine	NULL
.	NULL

The	NULL
available	NULL
evidence	NULL
indicates	NULL
that	NULL
vincristine	NULL
and	NULL
other	NULL
vinca	NULL
alkaloids	NULL
inhibit	NULL
microtubule	NULL
assembly	NULL
(	NULL
68	NULL
)	NULL
.	NULL

Of	NULL
interest	NULL
,	NULL
other	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
tubulin	NULL
polymerization	NULL
appears	NULL
to	NULL
be	NULL
necessary	NULL
for	NULL
induction	NULL
of	NULL
the	NULL
differentiated	NULL
phenotype	NULL
in	NULL
HL-60	NULL
cells	NULL
(	NULL
69	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
microtubules	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
functionally	NULL
related	NULL
to	NULL
the	NULL
intracellular	NULL
transport	NULL
of	NULL
some	NULL
proteins	NULL
(	NULL
70	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
cytoskeletal	NULL
changes	NULL
associated	NULL
with	NULL
vincristine	NULL
resistance	NULL
may	NULL
contribute	NULL
to	NULL
loss	NULL
of	NULL
TPA-induced	NULL
signaling	NULL
events	NULL
,	NULL
such	NULL
as	NULL
translocation	NULL
of	NULL
PKC	NULL
and	NULL
downstream	NULL
events	NULL
that	NULL
contribute	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
differentiated	NULL
monocytic	NULL
phenotype	NULL
.	NULL

Acknowledgment-We	NULL
gratefully	NULL
acknowledge	NULL
Dr.	NULL
Melvin	NULL
Center	NULL
for	NULL
providing	NULL
the	NULL
HL-60/vine	NULL
and	NULL
HL-60/vinc/R	NULL
cell	NULL
lines	NULL
and	NULL
for	NULL
helpful	NULL
suggestions	NULL
and	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

REFERENCES	NULL
Vogt	NULL
,	NULL
P.	NULL
K.	NULL
,	NULL
Bos	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
and	NULL
Doolittle	NULL
,	NULL
R.	NULL
F.	NULL
(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

84	NULL
,	NULL
3316-3319	NULL
.	NULL

Bohmann	NULL
,	NULL
D.	NULL
,	NULL
Bos	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Admon	NULL
,	NULL
A.	NULL
,	NULL
Nishimura	NULL
,	NULL
T.	NULL
,	NULL
Vogt	NULL
,	NULL
P.	NULL
K.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
288	NULL
,	NULL
1386-1392	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
Imagawa	NULL
,	NULL
M.	NULL
,	NULL
Chiu	NULL
,	NULL
R.	NULL
,	NULL
Stein	NULL
,	NULL
B.	NULL
,	NULL
Imbra	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Rahmsdorf	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Jonat	NULL
,	NULL
C.	NULL
,	NULL
Herrlich	NULL
,	NULL
P	NULL
and	NULL
Karm	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
49	NULL
,	NULL
729-739	NULL
.	NULL

Angel	NULL
P	NULL
Allegretto	NULL
,	NULL
E.	NULL
A	NULL
Okino	NULL
,	NULL
S	NULL
Hattori	NULL
,	NULL
K.	NULL
,	NULL
Boye	NULL
W.	NULL
J.	NULL
,	NULL
Hunter	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
332	NULL
166-171	NULL
.	NULL

Chlu	NULL
,	NULL
R.	NULL
,	NULL
Boyle	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Meek	NULL
,	NULL
J	NULL
Smeal	NULL
T.	NULL
,	NULL
Hunter	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
54	NULL
,	NULL
541â552	NULL
.	NULL

Lee	NULL
,	NULL
W.	NULL
,	NULL
Mitchell	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
49	NULL
,	NULL
741-752	NULL
.	NULL

Chiu	NULL
,	NULL
R.	NULL
,	NULL
Imagawa	NULL
,	NULL
M.	NULL
,	NULL
Imbra	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Bockoven	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
Nature	NULL
329	NULL
,	NULL
648-651	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
Hutton	NULL
K.	NULL
,	NULL
Smeal	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
55	NULL
,	NULL
875-885	NULL
.	NULL

Imler	NULL
,	NULL
J.	NULL
L	NULL
Schatz	NULL
,	NULL
C	NULL
Wasylyk	NULL
C.	NULL
,	NULL
Chatton	NULL
B.	NULL
,	NULL
and	NULL
Wasylyk	NULL
B	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Nature	NULL
332	NULL
275-27	NULL
.	NULL

Wasylyk	NULL
,	NULL
C.	NULL
,	NULL
Imler	NULL
,	NULL
J	NULL
L	NULL
and	NULL
Wasylyk	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

7	NULL
,	NULL
2475-2483	NULL
.	NULL

Schonthal	NULL
,	NULL
A	NULL
Herrlich	NULL
,	NULL
P.	NULL
,	NULL
Rahmsdorf	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
and	NULL
Ponta	NULL
,	NULL
H.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
54	NULL
,	NULL
325â334	NULL
.	NULL

Sistonen	NULL
L.	NULL
,	NULL
Holtta	NULL
,	NULL
E.	NULL
,	NULL
Maekla	NULL
,	NULL
T.	NULL
P.	NULL
,	NULL
Keski-Oja	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Alitalo	NULL
,	NULL
K.	NULL
(	NULL
1989	NULL
)	NULL
EMBOJ	NULL
8	NULL
815-8	NULL
22	NULL
.	NULL

Halazonetis	NULL
,	NULL
T	NULL
D.	NULL
,	NULL
Georgopoulos	NULL
,	NULL
K.	NULL
,	NULL
Greenberg	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
and	NULL
Leder	NULL
,	NULL
P.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
55	NULL
,	NULL
917-	NULL
924	NULL
.	NULL

Nakabeppu	NULL
,	NULL
Y.	NULL
,	NULL
Ryder	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Nathans	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
55	NULL
,	NULL
907-915	NULL
.	NULL

Zerlal	NULL
M.	NULL
,	NULL
Toschi	NULL
,	NULL
L.	NULL
,	NULL
Ryseck	NULL
R.	NULL
,	NULL
Schuermann	NULL
M.	NULL
,	NULL
Muller	NULL
R.	NULL
,	NULL
and	NULL
Bravo	NULL
,	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
805-813	NULL
.	NULL

Pertovaara	NULL
L.	NULL
,	NULL
sttonen	NULL
,	NULL
L.	NULL
,	NULL
Bos	NULL
,	NULL
T.	NULL
,	NULL
Vogt	NULL
,	NULL
P.	NULL
,	NULL
Keski-Oja	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Alitalo	NULL
,	NULL
K.	NULL
(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
,	NULL
9	NULL
1255-	NULL
1262	NULL
.	NULL

Carter	NULL
,	NULL
R.	NULL
,	NULL
Cosenza	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Pena	NULL
,	NULL
A.	NULL
,	NULL
Lipson	NULL
,	NULL
K.	NULL
,	NULL
Soprano	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
and	NULL
Soprano	NULL
K.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
OncogenBG	NULL
229-235	NULL
.	NULL

Kovary	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Bravo	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
4466-4472	NULL
.	NULL

de	NULL
Groot	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
Kruyt	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
van	NULL
der	NULL
Saag	NULL
,	NULL
P.	NULL
T.	NULL
,	NULL
and	NULL
Kruijer	NULL
,	NULL
W.	NULL
(	NULL
1990	NULL
)	NULL
EMBOJ	NULL
9	NULL
,	NULL
1831	NULL
1837	NULL
.	NULL

Sherman	NULL
,	NULL
M.	NULL
L	NULL
Stone	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Datta	NULL
,	NULL
R.	NULL
,	NULL
Bernstein	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D	NULL
w.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Btol	NULL
Chem	NULL
.	NULL

265	NULL
3320-	NULL
3323	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Cell	NULL
Growth	NULL
.	NULL

Nakamura	NULL
,	NULL
T.	NULL
,	NULL
Datta	NULL
,	NULL
R.	NULL
,	NULL
Kharbanda	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D	NULL
er	NULL
,	NULL
F.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Kraft	NULL
,	NULL
A.	NULL
S.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
Rfo	NULL
wg	NULL
aus	NULL
oa	NULL
e	NULL
g	NULL
mo	NULL
bo	NULL
a	NULL
co	NULL
tea	NULL
het	NULL
Hoobs	NULL
fos	NULL
M=	NULL
0	NULL
ra	NULL
to	NULL
go	NULL
NO	NULL
No	NULL
Ho	NULL
Â©	NULL
&	NULL
Differ	NULL
.	NULL

2	NULL
,	NULL
267-279	NULL
.	NULL

William	NULL
,	NULL
F.	NULL
Wagn	NULL
265	NULL
,	NULL
18166-18171	NULL
.	NULL

Szabo	NULL
,	NULL
E	NULL
Preis	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
Brown	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
and	NULL
Birrer	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Cell	NULL
Growth	NULL
&	NULL
szfer	NULL
2	NULL
,	NULL
475-482	NULL
.	NULL

Huberman	NULL
,	NULL
E	NULL
and	NULL
Callahan	NULL
,	NULL
M.	NULL
P.	NULL
(	NULL
1979	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

76	NULL
,	NULL
1293	NULL
1297	NULL
.	NULL

Lotem	NULL
H.	NULL
,	NULL
and	NULL
Sachs	NULL
,	NULL
L.	NULL
(	NULL
1979	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

76	NULL
,	NULL
5158~	NULL
5162	NULL
.	NULL

Rovera	NULL
,	NULL
G.	NULL
,	NULL
O'Breine	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
Diamond	NULL
,	NULL
L.	NULL
(	NULL
1979	NULL
)	NULL
Science	NULL
204	NULL
,	NULL
868-870	NULL
.	NULL

Datta	NULL
,	NULL
R	NULL
Sherman	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Stone	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
Growth	NULL
&	NULL
sz/er	NULL
2	NULL
,	NULL
43-49	NULL
bo	NULL
bo	NULL
Mo	NULL
N	NULL
Or	NULL
&	NULL
G	NULL
Â°	NULL
N	NULL
BQ	NULL
bo	NULL
~10	NULL
28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
,	NULL
Vincristine	NULL
Resistance	NULL
Blocks	NULL
TPA-mediated	NULL
Signaling	NULL
Events	NULL
Sariban	NULL
,	NULL
E.	NULL
,	NULL
Mitchell	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
W.	NULL
(	NULL
1985	NULL
)	NULL
Nature	NULL
316	NULL
,	NULL
64-66	NULL
Horiguchi	NULL
,	NULL
J.	NULL
,	NULL
Spriggs	NULL
,	NULL
D.	NULL
,	NULL
Imamura	NULL
,	NULL
K.	NULL
,	NULL
Stone	NULL
,	NULL
R.	NULL
,	NULL
Luebbers	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
252-258	NULL
McGrath	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Center	NULL
,	NULL
M.	NULL
S.	NULL
(	NULL
1988	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

48	NULL
,	NULL
3959-3963	NULL
Ma	NULL
,	NULL
L.	NULL
,	NULL
Marquardt	NULL
,	NULL
D.	NULL
,	NULL
Takemoto	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Center	NULL
,	NULL
M.	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
Chem	NULL
.	NULL

266	NULL
,	NULL
5593-5599	NULL
Chirgwin	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Przybyla	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
MacDonald	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Rutter	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
Biochemistry	NULL
18	NULL
,	NULL
5294-5299	NULL
Ryder	NULL
,	NULL
K.	NULL
,	NULL
Lau	NULL
,	NULL
L.	NULL
F.	NULL
,	NULL
and	NULL
Nathans	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
1487-1491	NULL
Curran	NULL
,	NULL
T.	NULL
,	NULL
McConnell	NULL
,	NULL
W.	NULL
P.	NULL
,	NULL
Van	NULL
Straaten	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1983	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

3	NULL
,	NULL
914-921	NULL
Zerial	NULL
,	NULL
M.	NULL
,	NULL
Toschi	NULL
,	NULL
L.	NULL
,	NULL
Ryseck	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
Schuermann	NULL
,	NULL
M.	NULL
,	NULL
Muller	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Bravo	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
805-813	NULL
Cohen	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
and	NULL
Curran	NULL
,	NULL
T.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
2063-2069	NULL
Cleveland	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Lopata	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
MacDonald	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Cowan	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
Rutter	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
and	NULL
Kirschner	NULL
,	NULL
M.	NULL
W.	NULL
(	NULL
1980	NULL
)	NULL
Cell	NULL
20	NULL
,	NULL
95-105	NULL
Kawasaki	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
Ladner	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Wang	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Van	NULL
Arsell	NULL
,	NULL
J.	NULL
,	NULL
Warren	NULL
,	NULL
M.	NULL
K	NULL
,	NULL
Coyne	NULL
,	NULL
M.	NULL
Y.	NULL
,	NULL
Schweickart	NULL
,	NULL
V.	NULL
L.	NULL
,	NULL
Lee	NULL
,	NULL
M.-T.	NULL
,	NULL
Wilson	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
Boosman	NULL
,	NULL
9	NULL
A.	NULL
,	NULL
Stanley	NULL
,	NULL
E.	NULL
R	NULL
Ralph	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Mark	NULL
D.	NULL
F.	NULL
(	NULL
1985	NULL
)	NULL
Science	NULL
230	NULL
291-	NULL
Wang	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Creasey	NULL
,	NULL
A	NULL
A.	NULL
,	NULL
Ladner	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Lin	NULL
,	NULL
L.	NULL
S.	NULL
,	NULL
Strickler	NULL
,	NULL
J.	NULL
,	NULL
Van	NULL
Arsdell	NULL
,	NULL
J.	NULL
N	NULL
Yamamoto	NULL
,	NULL
R	NULL
and	NULL
Mark	NULL
D.	NULL
F.	NULL
(	NULL
1985	NULL
)	NULL
Scuance	NULL
228	NULL
149-4	NULL
15	NULL
Staggâ	NULL
%	NULL
3M	NULL
.	NULL

,	NULL
Sariban	NULL
,	NULL
E.	NULL
,	NULL
Pettit	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
W.	NULL
(	NULL
1988	NULL
)	NULL
Blood	NULL
72	NULL
,	NULL
Yasuda	NULL
,	NULL
L.	NULL
,	NULL
Kishimoto	NULL
,	NULL
A.	NULL
,	NULL
Tanaka	NULL
,	NULL
S.	NULL
,	NULL
Tominaga	NULL
,	NULL
M.	NULL
,	NULL
Sakurai	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Nishizuka	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Biochem	NULL
.	NULL

Bio	NULL
;	NULL
dphys	NULL
Res	NULL
.	NULL

Commun	NULL
.	NULL

166	NULL
,	NULL
1220-1227	NULL
Sanghera	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Paddon	NULL
,	NULL
H.	NULL
B.	NULL
,	NULL
Ba	NULL
Â«	NULL
S.	NULL
A.	NULL
,	NULL
and	NULL
Pelech	NULL
,	NULL
S.	NULL
L	NULL
{	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
52-57	NULL
Gallego	NULL
,	NULL
C.	NULL
,	NULL
Gupta	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
Heasley	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
Qian	NULL
,	NULL
N.	NULL
X.	NULL
,	NULL
and	NULL
Johnson	NULL
,	NULL
G.	NULL
L.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
7355-7359	NULL
Pulverer	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
Kyriakis	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Avruch	NULL
,	NULL
J.	NULL
,	NULL
Nikolakaki	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Woodgett	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
353	NULL
,	NULL
670-674	NULL
Solomon	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
O'Driscoll	NULL
,	NULL
K.	NULL
,	NULL
Sosne	NULL
,	NULL
G.	NULL
,	NULL
Weinstein	NULL
,	NULL
I	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Cayre	NULL
,	NULL
Y.	NULL
E.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
Growth	NULL
&	NULL
Differ	NULL
.	NULL

2	NULL
,	NULL
187-194	NULL
Cohen	NULL
,	NULL
P.	NULL
,	NULL
Holmes	NULL
,	NULL
C.	NULL
F.	NULL
B.	NULL
,	NULL
and	NULL
Tsukitani	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

15	NULL
,	NULL
98-102	NULL
Adunyah	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Unlap	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Franklin	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
and	NULL
Kraft	NULL
,	NULL
A.	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

151	NULL
,	NULL
415-426	NULL
Kharbanda	NULL
,	NULL
S.	NULL
,	NULL
Datta	NULL
,	NULL
R.	NULL
,	NULL
Rubin	NULL
,	NULL
E.	NULL
,	NULL
Nakamura	NULL
,	NULL
T.	NULL
,	NULL
Hass	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
W.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
Growth	NULL
&	NULL
Differ	NULL
.	NULL

8	NULL
,	NULL
391-399	NULL
Nishizuka	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Nature	NULL
308	NULL
,	NULL
693-697	NULL
50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

12273	NULL
Aquino	NULL
,	NULL
A.	NULL
,	NULL
Hartman	NULL
,	NULL
K.	NULL
D.	NULL
,	NULL
Knode	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Grant	NULL
,	NULL
S.	NULL
,	NULL
Huang	NULL
,	NULL
K.-P.	NULL
,	NULL
Niu	NULL
,	NULL
C.-H.	NULL
,	NULL
and	NULL
Glazer	NULL
,	NULL
R.	NULL
I	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

48	NULL
,	NULL
3324-3329	NULL
Bhalla	NULL
,	NULL
K.	NULL
,	NULL
Hindenburg	NULL
,	NULL
A.	NULL
,	NULL
Taub	NULL
,	NULL
R.	NULL
N.	NULL
,	NULL
and	NULL
Grant	NULL
,	NULL
S.	NULL
(	NULL
1985	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

45	NULL
,	NULL
3657-3662	NULL
Hayashi	NULL
,	NULL
M.	NULL
,	NULL
Okabe-Kado	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Hozumi	NULL
,	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
Leuk	NULL
.	NULL

Res	NULL
.	NULL

10	NULL
,	NULL
1051-1057	NULL
Beck	NULL
,	NULL
W.	NULL
T.	NULL
,	NULL
Cirtain	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Ashmun	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Mirro	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

46	NULL
,	NULL
4571-4575	NULL
Melloni	NULL
,	NULL
E.	NULL
,	NULL
Pontremoli	NULL
,	NULL
S.	NULL
,	NULL
Damiani	NULL
,	NULL
G.	NULL
,	NULL
Viotti	NULL
,	NULL
P.	NULL
,	NULL
Weich	NULL
,	NULL
N.	NULL
,	NULL
Rifkind	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Marks	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
,	NULL
U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
3835-3839	NULL
Melloni	NULL
,	NULL
E.	NULL
,	NULL
Pontremoli	NULL
,	NULL
S.	NULL
,	NULL
Sparatore	NULL
,	NULL
B.	NULL
,	NULL
Patrone	NULL
,	NULL
M.	NULL
,	NULL
Grossi	NULL
,	NULL
F.	NULL
,	NULL
Marks	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Rifkind	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
4417-4420	NULL
Michaeli	NULL
,	NULL
J.	NULL
,	NULL
Lebedev	NULL
,	NULL
Y	NULL
.	NULL

B.	NULL
,	NULL
Richon	NULL
,	NULL
V.	NULL
M.	NULL
,	NULL
Chen	NULL
,	NULL
Z.-X	NULL
.	NULL

,	NULL
Marks	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Rifkind	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
3535-3540	NULL
Chiu	NULL
,	NULL
R.	NULL
,	NULL
Angel	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
59	NULL
,	NULL
979-986	NULL
Schutte	NULL
,	NULL
J.	NULL
,	NULL
Viallet	NULL
,	NULL
J.	NULL
,	NULL
Nau	NULL
,	NULL
M.	NULL
,	NULL
Segal	NULL
,	NULL
S.	NULL
,	NULL
Fedorko	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Minna	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Cell	NULL
59	NULL
,	NULL
987-997	NULL
Homma	NULL
,	NULL
Y.	NULL
,	NULL
Henning-Chubb	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
and	NULL
Huberman	NULL
,	NULL
E.	NULL
(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
7316-7319	NULL
Datta	NULL
,	NULL
R.	NULL
,	NULL
Hallahan	NULL
,	NULL
D.	NULL
,	NULL
Kharbanda	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Rubin	NULL
,	NULL
E.	NULL
,	NULL
Sherman	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Huberman	NULL
,	NULL
E.	NULL
,	NULL
Weichselbaum	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
W.	NULL
(	NULL
1992	NULL
)	NULL
Biochemistry	NULL
31	NULL
,	NULL
8300-8306	NULL
Mitchell	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Henning-Chubb	NULL
,	NULL
C.	NULL
,	NULL
Huberman	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
45	NULL
,	NULL
497-504	NULL
Tonetti	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Horio	NULL
,	NULL
M.	NULL
,	NULL
Collart	NULL
,	NULL
F.	NULL
R.	NULL
,	NULL
and	NULL
Huberman	NULL
,	NULL
E.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
Growth	NULL
&	NULL
Differ	NULL
.	NULL

3	NULL
,	NULL
139-745	NULL
Nishikawa	NULL
,	NULL
M.	NULL
,	NULL
Komada	NULL
,	NULL
F.	NULL
,	NULL
Uemura	NULL
,	NULL
Y.	NULL
,	NULL
Hidaka	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Shirakawa	NULL
,	NULL
S.	NULL
(	NULL
1990	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

50	NULL
,	NULL
621-626	NULL
Aihara	NULL
,	NULL
H.	NULL
,	NULL
Asaoka	NULL
,	NULL
Y.	NULL
,	NULL
Yoshida	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Nishizuka	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
11062-11066	NULL
Fine	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Patel	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Chabner	NULL
,	NULL
B	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
582-586	NULL
StigtBSi	NULL
J.	NULL
,	NULL
Marquardt	NULL
D.	NULL
,	NULL
and	NULL
Center	NULL
,	NULL
M.	NULL
S.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
Hocevar	NULL
,	NULL
B	NULL
A	NULL
and	NULL
Fields	NULL
,	NULL
A.	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
28-33	NULL
Joggzg	NULL
.	NULL

A.	NULL
,	NULL
Thrower	NULL
D	NULL
and	NULL
Wilson	NULL
,	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
Cancer	NULL
Res	NULL
51	NULL
,	NULL
2212-	NULL
Legingg	NULL
,	NULL
$	NULL
f/	NULL
â	NULL
I	NULL
â	NULL
i-F.	NULL
,	NULL
Sokoloski	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Sartorelli	NULL
,	NULL
A.	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

52	NULL
,	NULL
Maxwell	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Ames	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
Sawai	NULL
,	NULL
E.	NULL
T.	NULL
,	NULL
Decker	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Cook	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
and	NULL
Butel	NULL
,	NULL
J.	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
Growth	NULL
&	NULL
Differ	NULL
.	NULL

2	NULL
,	NULL
115-127	NULL
Bradford	NULL
,	NULL
M.	NULL
M.	NULL
(	NULL
1976	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

72	NULL
,	NULL
248-254	NULL

